Synthesis of Fluorosugar Reagents for the Construction of Well-Defined Fluoroglycoproteins
Abstract

2-Deoxy-2-fluoroglycosyl iodides are privileged glycosyl donors for the stereoselective preparation of 1-Nu-β-fluorosugars, which are useful reagents for chemical site-selective protein glycosylation. Ready access to such β-fluorosugars enables the mild and efficient construction of well-defined fluoroglycoproteins.
F-glycopeptides(1-9) and the more recently disclosed F-glycoproteins(10-19) are promising candidates for the preparation of synthetic carbohydrate vaccines(20) and hold great potential as a new generation of [18F]-(glyco)radiopharmaceuticals(21, 22) and tracers for the noninvasive imaging techniques positron emission tomography (18F-PET)(23, 24) and magnetic resonance/magnetic resonance imaging (19F-MR/MRI).(25) In addition to the development of more efficient methods for protein/peptide modification,(26) it is also pivotal to access pure F-sugar reagents and building blocks for such transformations. These glycosyl units typically include in their structure reactive handles such as azides (for copper(I)-catalyzed azide–alkyne cycloaddition–CuAAC and Staudinger ligations)(17) or chalcogens in the form of sulfhydryl groups or diselenide moieties (for exchange reactions with Cys or additions to dehydroalanine),(14, 15) which upon reaction generate a new carbohydrate–protein conjugate. Retrosynthetic analysis revealed that 2-F-glycosyl halides are suitable glycosyl donors for the preparation of such reagents via biphasic glycosylations/phase-transfer catalyzed reactions (PTC). These moieties enable exquisite control of β-anomeric selectivity (via SN2-like mechanism) during the introduction of the reactive handle, which is typically a “soft” nucleophilic moiety.(27) There are two general strategies (one-pot from glycals vs two-step from 2-F-pyranoses) for the preparation of 1-β-“soft Nu”-2-deoxy-2-fluoroglycosides using electrophilic F+ reagents (Scheme 1).(28) While the one-pot strategy works well for certain configurations (e.g., Gal), the two-step approach is more general and thus preferred for the preparation of pure F-sugar reagents in a more efficient and homogeneous manner (giving a better overall yield and controlled Fax/eq diastereoselectivity).
Scheme 1

Among glycosyl halides, iodides(29) have been recently utilized in several glycosylation strategies and provide a robust platform for PTC reactions, perhaps leading to higher yields compared to chlorides or bromides due to their superior leaving group properties under SN2-like reaction conditions. There are very few examples of 2-F- and 2,2-diF-glycosyl iodides. This rare class of glycosyl donors include some isolated examples of 2-F- and 2,2-diF-pyranosides(30-32) and our 2-F-galactopyranosyl iodide prepared via a “one-pot” strategy, as revealed by VT-NMR experiments (see Supporting Information),(33) and more recently 2,2-diF-furanosides.(34) Despite their great potential, low preparative yields in the pyranose series and inseparable α/β mixtures in the case of furanoses has so far hampered their wide utilization as β-selective glycosyl donors in PTC protocols.
In this work, we envisioned a “two-step” strategy for the preparation of 2-F-glycosyl iodides from ready available 2-F-glycosyl-1-O-Ac derivatives that might overcome such limitations enabling a more efficient preparation of this class of highly reactive glycosyl donors. We then sought to explore their reactivity for the preparation of fluorosugar reagents that would serve as useful moieties to achieve site-selective chemical glycosylation of proteins. We first evaluated the reaction conditions using 2-F-α/β-galactopyranose 1 (Table 1). Initial experiments revealed TMSI(35) to be an effective promoter for the preparation of glycosyl iodide 2a, although the reaction only proceeded in 57% yield after two consecutive reaction cycles (entry 1). We found that addition of MgO(36) that acts as a scavenger for the in situ generated TMSOAc avoids the reversible formation of starting 1, while increasing the yields up to 78% (entry 2). Good yields (up to 85% in a single reaction cycle) were finally obtained by increasing the amount of both TMSI (2.2 equiv) and MgO (4 equiv) as well as reducing the reaction temperature (from reflux to rt) in order to avoid detrimental side reactions (entry 3). Other promoters were also evaluated (entries 4–7). While the use of HMDS/I2 proved ineffective and complex mixtures of products were observed (entry 7),(37) the in situ formation of highly reactive HI by refluxing AcSH and I2 allowed the formation of the desired iodide 2a, albeit in lower yields compared to TMSI (up to 54%) (entries 4–6).(38) Interestingly, the use of MgO was found to be costly (24%) when using AcSH and I2 probably due to its incompatibility with AcSH and/or HI (entry 4). 2-F-galactosyl bromide 2b was also prepared following a reported procedure in 95% yield (Table 1, entry 8).(39) With the optimized conditions in hand we set out to evaluate the scope of the iodination with other configurations (Table 2). Conditions A (with TMSI) were utilized with 2-F-α/β-pyranoses of Glc3 and Man4 configuration affording desired glycosyl iodides 5a and 6a in moderate yields (entries 1 and 4). To our delight, conditions B (with AcSH and I2) improved the yield to 82% for 5a and 75% for 6a (entries 2 and 5). 2-F-glycosyl bromides 5b and 6b were also prepared in excellent yields (up to 98%) using the standard conditions (entries 3 and 6). Practical yields of the corresponding α-glycosyl iodides as sole anomers (e.g., 1JC1–H1 = 187.6 Hz, 3J1,2 = 4.7 Hz, and 3J3,4 = 10.2 Hz in 5a, 4C1 conformation)(40) were obtained regardless of the pyranoside configuration (Gal, Glc, and Man).

| entry | conditions (equiv) | product | yield (%) |
|---|---|---|---|
| 1 | TMSI (1), rt, 8 h | 2a | 57b |
| 2 | TMSI (1.1), MgO (2), reflux, 12 h | 2a | 78b |
| 3 | TMSI (2.2), MgO (4), rt, 24 h | 2a | 85 |
| 4 | AcSH (1.7), I2 (0.8), MgO (2), reflux, 30 h | 2a | 24b |
| 5 | AcSH (4.4), I2 (2), reflux, 12 h | 2a | 34b |
| 6 | AcSH (2.2), I2 (1), reflux, 12 h | 2a | 54b |
| 7 | HMDS (0.6), I2 (0.6), rt, 24 h | 2a | mixture |
| 8 | 33% HBr in AcOH, rt, 8 h | 2b | 95 |
General conditions: 2-F-α/β-galactopyranose 1 (2:1 α/β) (1 equiv) in dry CH2Cl2 (0.1 M) unless otherwise indicated.
Isolated yield after two consecutive reaction cycles. TMS = trimethylsilyl, HMDS = hexamethyldisilazane.

General conditions: 2-F-α/β-pyranose (1:0–1:3 α/β) (1 equiv) in dry CH2Cl2 (0.1 M) unless otherwise indicated.
Isolated yield after two consecutive reaction cycles. Conditions A: TMSI (2.2 equiv), MgO (4 equiv), rt, 30 h. Conditions B: AcSH (2.2), I2 (1), reflux, 5 h. Conditions C: 33% HBr in AcOH, rt, 3–8 h. TMS = trimethylsilyl.
2-F-glycosyl iodides proved stable and were purified by SiO2 flash column chromatography with no decomposition observed. They are also UV visible (at 254 nm) providing an easy experimental follow-up. Similar to other protocols that use strong acid activators (e.g., HBr), base sensitive acetyl groups are the more appropriate protecting groups for the overall synthetic route (Selectfluor–halogenation–PTC–deprotection). Acetyl protecting groups are easily introduced, prove stable under the sequence of transformations, and are easily removed under Zemplén conditions to afford the final unprotected and ready-to-conjugate fluorosugar reagents. Other acid sensitive groups such as tert-butyldiphenylsilyl (TBDPSi) were not tolerated under the optimized acid–based reaction conditions, and extensive deprotection was observed.
Next, the synthesis of 1-β-“soft Nu”-2-deoxy-2-fluoroglycosides was attempted using 2-F-glycosyl halides 2a,b and 5–6a,b (Scheme 2). A wide range of N-, S-, and Se-nucleophiles led to β-fluorosugar reagents 7–10, useful for chemical protein glycosylation strategies,(14, 15, 17) even including those with the challenging 1-β-cis-Man(41) disposition 9a–c. Excellent yields (up to 98%) and pure β-selectivity (e.g., 1JC1–H1 = 162.7 Hz, 3J1,2 = 10.6 Hz, and 3J3,4 = 9.5 Hz in 8c, 4C1 conformation)(40) were always obtained. Iodides proved slightly better in terms of yield (ca. 10–15%) over their bromide counterparts using a better Nu in a “match” scenario of reactivity. We believe the low reactivity of mannosyl-1-halides is probably due to unfavorable dipolar interactions between the donor and the incoming Nu and/or conformational issues that reduce the reaction rate. This made competitive otherwise negligible side reactions that reduce the overall yield.(42) A weaker Nu such as sodium benzenethiosulfonate (NaPTS)(43) necessitated the use of more reactive iodides and afforded moderate-to-good yields (88% for I vs 45% for Br in 10a). Our data indicate that 2-F-glycosyl iodides are needed when using weaker nucleophiles. The reported 2-F-glycosyl iodides may also find broader utility for example in the preparation of advanced fluorinated building blocks such as O-linked natural product mimetics(44)11a and covalent inhibitors(45, 46) of carbohydrate processing enzymes 11b and 12 where the use of “soft” nucleophilic acceptors are required. Finally, to illustrate the application of such reagents and further complement our previous reports on the preparation of a variety of well-defined triazole,(17) thioether,(15, 18) and SeS-linked(14, 18) fluorinated glycoproteins including their [18F]-counterparts, we examined the reaction between Cys-specific Ac3GlcF(9) and Ac3GalF-1-PTS reagents 10a,b with Annexin V 13. This protein displays a unique naturally occurring surface exposed Cys and is widely utilized as a marker of apoptosis (Scheme 3).(47) Indeed, reaction of 10a or 10b with Annexin V 13 in 20 mM Tris HCl buffer pH 8 and 10% CH3CN, which was used to ensure reagent solubility, gave the expected homogeneous disulfide-linked F-glycoproteins 14a,b in >95% conversion after 1 h at rt. This is demonstrative of the utility of the reagents that can now be easily prepared from the 2-F-glycosyl iodide reagents we have reported in this work. Moreover, this methodology is amenable to utilization in 18F-PET imaging using the corresponding [18F]-glyco-1-PTS reagents.(9)
Scheme 2

aGeneral conditions: 2-F-α-pyranosyl halide (1 equiv), Nu (2 equiv), TBAHS (2 equiv) in 5:1 EtOAc–1 M Na2CO3 aq (0.04 M), rt, from 1 h up to 7 days unless otherwise indicated.
Determined by 19F NMR of the crude reaction mixture.
2-F-α-galactosyl bromide 2b (1 equiv), Nu (2 equiv), TBAB (2 equiv) in 3:2 CH2Cl2–5% NaOH aq (0.02 M), rt, 14–22 h.
2-F-α-galactosyl bromide 2b (2 equiv), estrone (1 equiv), 60% NaH in mineral oil (1.5 equiv) in dry 1,4-dioxane (0.08 M), rt, 24 h. Nu = nucleophile. TBAHS = tetrabutylammonium hydrogen sulfate. TBAB = tetrabutylammonium bromide.
Scheme 3

aGeneral conditions: Annexin V 13 (1 mg mL–1) (1 equiv), 2-F-sugar reagent 10a,b (250 equiv) in 20 mM Tris HCl buffer (pH 8.0) and 10% CH3CN, rt, 1 h.
In summary, we have disclosed a general strategy for accessing a wide range of 1-Nu-2-fluorosugars that are useful reagents for chemical-site-selective protein glycosylation. The glycosyl iodide intermediates prepared here possess a seemly balance between stability and reactivity that facilitates their preparation, purification, and storage. Importantly, these intermediates also ensure product homogeneity by their exquisite β-control during stereoselective glycosylation with a “soft” Nu (via SN2-like reactions). The reported F-sugar reagents will find broad utility for building not only homogeneous 19F- but also [18F]-glycoprobes that are valuable tools in the fields of chemical biology and biomedical imaging.
Experimental details, VT-NMR experiments, characterization data, and copies of 1H, 13C, and 19F NMR spectra for all new compounds. The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acs.orglett.5b01259.
The authors declare no competing financial interest.
Terms & Conditions
Electronic Supporting Information files are available without a subscription to ACS Web Editions. The American Chemical Society holds a copyright ownership interest in any copyrightable Supporting Information. Files available from the ACS website may be downloaded for personal use only. Users are not otherwise permitted to reproduce, republish, redistribute, or sell any Supporting Information from the ACS website, either in whole or in part, in either machine-readable form or any other form without permission from the American Chemical Society. For permission to reproduce, republish and redistribute this material, requesters must process their own requests via the RightsLink permission system. Information about how to use the RightsLink permission system can be found at http://pubs.acs.org/page/copyright/permissions.html.
Acknowledgment
We thank the European Commission (Marie Curie CIG, O.B. and G.J.L.B.), MICINN, Spain (Juan de la Cierva Fellowship, O.B.), MINECO, Spain (CTQ2011-22872BQU), and Generalitat de Catalunya (M.S.) for generous financial support. We also thank Mr. Adrià Cardona-Benages (URV) for technical assistance. G.J.L.B. thanks the Royal Society (University Research Fellowship), Fundação para a Ciência a Tecnologia, Portugal (FCT Investigator), and the EPSRC for funding.
References
This article references 47 other publications.
- 1Johannes, M.; Reindl, M.; Gerlitzki, B.; Schmitt, E.; Hoffmann-Röder, A. Beilstein J. Org. Chem. 2015, 11, 155– 161[ Crossref], [ PubMed], [ CAS], Google Scholar1https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1ylu78%253D&md5=025648c9b782957da623e355e822c2afSynthesis and biological evaluation of a novel MUC1 glycopeptide conjugate vaccine candidate comprising a 4'-deoxy-4'-fluoro-Thomsen-Friedenreich epitopeJohannes, Manuel; Reindl, Maximilian; Gerlitzki, Bastian; Schmitt, Edgar; Hoffmann-Roeder, AnjaBeilstein Journal of Organic Chemistry (2015), 11 (), 155-161/1-155-161/7, 7 pp.CODEN: BJOCBH; ISSN:1860-5397. (Beilstein-Institut zur Foerderung der Chemischen Wissenschaften)The development of selective anticancer vaccines that provide enhanced protection against tumor recurrence and metastasis has been the subject of intense research in the scientific community. The tumor-assocd. glycoprotein MUC1 represents a well-established target for cancer immunotherapy and has been used for the construction of various synthetic vaccine candidates. However, many of these vaccine prototypes suffer from an inherent low immunogenicity and are susceptible to rapid in vivo degrdn. To overcome these drawbacks, novel fluorinated MUC1 glycopeptide-BSA/TTox conjugate vaccines have been prepd. Immunization of mice with the 4'F-TF-MUC1-TTox conjugate resulted in strong immune responses overriding the natural tolerance against MUC1 and producing selective IgG antibodies that are cross-reactive with native MUC1 epitopes on MCF-7 human cancer cells.
- 2Lamandé-Langle, S.; Collet, C.; Hensienne, R.; Vala, C.; Chrétien, F.; Chapleur, Y.; Mohamadi, A.; Lacolley, P.; Regnault, V. Bioorg. Med. Chem. 2014, 22, 6672– 6683[ Crossref], [ PubMed], [ CAS], Google Scholar2https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslelsr3F&md5=386b0c006baac912d7c3e14cf9ce5e70'Click' glycosylation of peptides through cysteine propargylation and CuAACLamande-Langle, Sandrine; Collet, Charlotte; Hensienne, Raphael; Vala, Christine; Chretien, Francoise; Chapleur, Yves; Mohamadi, Amel; Lacolley, Patrick; Regnault, VeroniqueBioorganic & Medicinal Chemistry (2014), 22 (23), 6672-6683CODEN: BMECEP; ISSN:0968-0896. (Elsevier B.V.)'Click' glycosylation of cysteine-contg. peptides were carried out in good yield by copper(I)-catalyzed azide-alkyne cycloaddn. (CuAAC). For that peptides were functionalized though direct propargylation of the cysteine residue allowing their use in CuAAC with suitable free or protected azido sugars of gluco, manno and galacto configuration. Among these free and protected glycopeptides a series of 'glycoRGD' peptides were obtained and submitted to in vitro platelet aggregation tests, showing that the pseudoglycosylation of the adhesion sequence lowers the IC50 value and thus could improve the in vivo pharmacokinetic properties.
- 3Dall’Angelo, S.; Zhang, Q.; Fleming, I. N.; Piras, M.; Schweiger, L. F.; O’Hagan, D.; Zanda, M. Org. Biomol. Chem. 2013, 11, 4551– 4558[ Crossref], [ PubMed], [ CAS], Google Scholar3https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpslClu7o%253D&md5=d09717a40cdbccedca2901a12c23c3d8Efficient bioconjugation of 5-fluoro-5-deoxy-ribose (FDR) to RGD peptides for positron emission tomography (PET) imaging of αvβ3 integrin receptorDall'Angelo, Sergio; Zhang, Qingzhi; Fleming, Ian N.; Piras, Monica; Schweiger, Lutz F.; O'Hagan, David; Zanda, MatteoOrganic & Biomolecular Chemistry (2013), 11 (27), 4551-4558CODEN: OBCRAK; ISSN:1477-0520. (Royal Society of Chemistry)The utility of 5-fluoro-5-deoxyribose (FDR) as an efficient bioconjugation agent for radiolabelling of the RGD peptides c(RGDfK) and c(RGDfC) is demonstrated. The bioconjugation is significantly superior to that achieved with 2-fluoro-2-deoxyglucose (FDG) and benefits from the location of the fluorine at C-5, and that ribose is a 5-membered ring sugar rather than a 6-membered ring. Both features favor ring opening to the aldehydic form of the sugar to promote smooth oxime ligation with aminooxy ether functionalised peptides. [18F]FDR was prepd. in this study by synthesis from fluoride-18 using an automated synthesis protocol adapting that used routinely for [18F]FDG. c(RGDfK) was functionalised with an aminooxyacetyl group (Aoa) via its lysine terminus, while c(RGDfC) was functionalised with an aminooxyhexylmaleimide (Ahm) through a cysteine-maleimide conjugation. Bioconjugation of [18F]FDR to c(RGDfC)-Ahm proved to be more efficient than c(RGDfK)-Aoa (92% vs. 65%). The unlabeled (19F) bioconjugates c(RGDfK)-Aoa-FDR and c(RGDfC)-Ahm-FDR were prepd. and their in vitro affinity to purified integrin αvβ3 was detd. c(RGDfK)-Aoa-FDR showed the greater affinity. Purified "hot" bioconjugates c(RGDfK)-Aoa-[18F]FDR and c(RGDfC)-Ahm-[18F]FDR were assayed by incubation with MCF7, LNCaP and PC3 cell lines. In both cases the conjugated RGD peptides showed selectivity for PC3 cells, which express αvβ3 integrin, with the c(RGDfK)-Aoa-[18F]FDR demonstrating better binding, consistent with its higher in vitro affinity. The study demonstrates that [18F]FDR is an efficient bioconjugation ligand for RGD bioactive peptides.
- 4Lang, C.; Maschauer, S.; Hübner, H.; Gmeiner, P.; Prante, O. J. Med. Chem. 2013, 56, 9361– 9365[ ACS Full Text
], [ CAS], Google Scholar4https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1yls7vJ&md5=baada842eccd8ae5393195087322d294Synthesis and Evaluation of a 18F-Labeled Diarylpyrazole Glycoconjugate for the Imaging of NTS1-Positive TumorsLang, Christopher; Maschauer, Simone; Huebner, Harald; Gmeiner, Peter; Prante, OlafJournal of Medicinal Chemistry (2013), 56 (22), 9361-9365CODEN: JMCMAR; ISSN:0022-2623. (American Chemical Society)Aiming to image NTS1 over-expressing tumors, the diarylpyrazole glycoconjugate I, derived from the potent NTS1 antagonist, was synthesized taking advantage of the palladium-catalyzed aminocarbonylation reaction. The glycoconjugate I displayed excellent affinity and selectivity toward NTS1. Radio-synthesis proceeded straightforwardly, obtaining [18F]-I with excellent stability and highly beneficial bio-distribution in vivo as demonstrated by PET imaging in HT29 tumor-bearing nude mice. Thus, the tracer [18F]-I represents a highly promising candidate for PET imaging of NTS1-pos. tumors. - 5Li, X.-G.; Dall’Angelo, S.; Schweiger, L. F.; Zanda, M.; O’Hagan, D. Chem. Commun. 2012, 48, 5247– 5249[ Crossref], [ PubMed], [ CAS], Google Scholar5https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtlOqsro%253D&md5=976a5461412c6d2a0f6ef0ae28c55d97[18F]-5-Fluoro-5-deoxyribose, an efficient peptide bioconjugation ligand for positron emission tomography (PET) imagingLi, Xiang-Guo; Dall'Angelo, Sergio; Schweiger, Lutz F.; Zanda, Matteo; O'Hagan, DavidChemical Communications (Cambridge, United Kingdom) (2012), 48 (43), 5247-5249CODEN: CHCOFS; ISSN:1359-7345. (Royal Society of Chemistry)[18F]-5-Fluoro-5-deoxyribose ([18F]-FDR) conjugates much more rapidly than [18F]-FDG under mild reaction conditions to peptides and offers new prospects for mild and rapid bioconjugation for fluorine-18 labeling in PET imaging.
- 6Maschauer, S.; Einsiedel, J.; Haubner, R.; Hocke, C.; Ocker, M.; Hübner, H.; Kuwert, T.; Gmeiner, P.; Prante, O. Angew. Chem., Int. Ed. 2010, 49, 976– 979[ Crossref], [ PubMed], [ CAS], Google Scholar6https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGmt7Y%253D&md5=c9dcd492a63cbbfe1c0542d95abaa6d8Labeling and Glycosylation of Peptides Using Click Chemistry: A General Approach to 18F-Glycopeptides as Effective Imaging Probes for Positron Emission TomographyMaschauer, Simone; Einsiedel, Juergen; Haubner, Roland; Hocke, Carsten; Ocker, Matthias; Huebner, Harald; Kuwert, Torsten; Gmeiner, Peter; Prante, OlafAngewandte Chemie, International Edition (2010), 49 (5), 976-979, S976/1-S976/18CODEN: ACIEF5; ISSN:1433-7851. (Wiley-VCH Verlag GmbH & Co. KGaA)Click chem. was used for 18F-labeling of glycopeptides for potential use as PET imaging agents.
- 7Hoffmann-Röder, A.; Kaiser, A.; Wagner, S.; Gaidzik, N.; Kowalczyk, D.; Westerlind, U.; Gerlitzki, B.; Schmitt, E.; Kunz, H. Angew. Chem., Int. Ed. 2010, 49, 8498– 8503[ Crossref], [ PubMed], [ CAS], Google Scholar7https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbis1CqtQ%253D%253D&md5=4ad8b8617c3c506d049a1ea8bdffe216Synthetic antitumor vaccines from tetanus toxoid conjugates of MUC1 glycopeptides with the Thomsen-Friedenreich antigen and a fluorine-substituted analogueHoffmann-Roder Anja; Kaiser Anton; Wagner Sarah; Gaidzik Nikola; Kowalczyk Danuta; Westerlind Ulrika; Gerlitzki Bastian; Schmitt Edgar; Kunz HorstAngewandte Chemie (International ed. in English) (2010), 49 (45), 8498-503 ISSN:.There is no expanded citation for this reference.
- 8Wuest, F.; Hultsch, C.; Berndt, M.; Bergmann, R. Bioorg. Med. Chem. Lett. 2009, 19, 5426– 5428[ Crossref], [ PubMed], [ CAS], Google Scholar8https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVeqsLvO&md5=a2b2972f5c6b3dfe917fbdf9259c673cDirect labelling of peptides with 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG)Wuest, Frank; Hultsch, Christina; Berndt, Mathias; Bergmann, RalfBioorganic & Medicinal Chemistry Letters (2009), 19 (18), 5426-5428CODEN: BMCLE8; ISSN:0960-894X. (Elsevier B.V.)The study describes the use of [18F]FDG as 18F building block for the direct labeling of various aminooxy-functionalised peptides via chemoselective oxime formation.
- 9Prante, O.; Einsiedel, J.; Haubner, R.; Gmeiner, P.; Wester, H.-J.; Kuwert, T.; Maschauer, S. Bioconjugate Chem. 2007, 18, 254– 262[ ACS Full Text
], [ CAS], Google Scholar9https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCgs7%252FE&md5=6db694427f3a27454386048a4c965e113,4,6-Tri-O-acetyl-2-deoxy-2-[18F]fluoroglucopyranosyl Phenylthiosulfonate: A Thiol-Reactive Agent for the Chemoselective 18F-Glycosylation of PeptidesPrante, Olaf; Einsiedel, Juergen; Haubner, Roland; Gmeiner, Peter; Wester, Hans-Juergen; Kuwert, Torsten; Maschauer, SimoneBioconjugate Chemistry (2007), 18 (1), 254-262CODEN: BCCHES; ISSN:1043-1802. (American Chemical Society)3,4,5-Tri-O-acetyl-2-[18F]fluoro-2-deoxy-D-glucopyranosyl 1-phenylthiosulfonate (I) was developed as a thiol-reactive labeling reagent for the site-specific 18F-glycosylation of peptides. Starting from 1,3,4,6-tetra-O-acetyl-2-deoxy-2-[18F]fluoroglucopyranose, a three-step radiochem. pathway was investigated and optimized, and I was obtained in a radiochem. yield of about 33% in 90 min (decay-cor. and based on starting [18F]fluoride). I was reacted with the model pentapeptide CAKAY, providing chemoselectivity and excellent conjugation yields of >90% under mild reaction conditions. The optimized method was adopted to the 18F-glycosylation of the αvβ3-affine peptide cyclo(RGDfC), achieving high conjugation yields (95%, decay-cor.). The αvβ3 binding affinity of the glycosylated cyclo(RGDfC) remained uninfluenced as detd. by competition binding studies vs. 125I-echistatin using both isolated αvβ3 and human umbilical vein endothelial cells (Ki = 68 ± 10 nM (αvβ3) vs. Ki = 77 ± 4 nM (HUVEC)). The whole radiosynthetic procedure, including the prepn. of I, peptide ligation, and final HPLC purifn., provided a decay-uncorrected radiochem. yield of 13% after a total synthesis time of 130 min. I can be used to prep. 18F-labeled bioactive S-glycopeptides for studying their pharmacokinetics in vivo by positron emission tomog. (PET). - 10Huo, C.-X.; Zheng, X.-J.; Xiao, A.; Liu, C.-C.; Sun, S.; Lv, Z.; Ye, X.-S. Org. Biomol. Chem. 2015, 13, 3677– 3690[ Crossref], [ PubMed], [ CAS], Google Scholar10https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2qtLY%253D&md5=dccf9199a88d330bdb4678ad4c6ad018Synthetic and immunological studies of N-acyl modified S-linked STn derivatives as anticancer vaccine candidatesHuo, Chang-Xin; Zheng, Xiu-Jing; Xiao, An; Liu, Chang-Cheng; Sun, Shuang; Lv, Zhuo; Ye, Xin-ShanOrganic & Biomolecular Chemistry (2015), 13 (12), 3677-3690CODEN: OBCRAK; ISSN:1477-0520. (Royal Society of Chemistry)It is well known that tumor cells express some aberrant glycans, termed tumor-assocd. carbohydrate antigens (TACAs). TACAs are good targets for the development of carbohydrate-based anticancer vaccines. However, one of the major problems is that carbohydrate antigens possess a weak immunogenicity. To tackle this problem, a no. of unnatural N-modified S-linked STn analogs were designed and prepd. Reaction of the modified STn disaccharides with bifunctional adipic acid p-nitrophenyl diester provided the corresponding activated esters, which was followed by the conjugation with keyhole limpet hemocyanin (KLH), affording the corresponding protein conjugates. The immunol. properties of these glycoconjugates were evaluated in a mouse model. The results showed that the modified glycoconjugates stimulated the prodn. of IgG antibodies that are capable of recognizing the naturally occurring STn antigen, helping the discovery of carbohydrate-based anticancer vaccine candidates.
- 11Lee, H.-Y.; Chen, C.-Y.; Tsai, T.-I.; Li, S.-T.; Lin, K.-H.; Cheng, Y.-Y.; Ren, C.-T.; Cheng, T.-J. R.; Wu, C.-Y.; Wong, C.-H. J. Am. Chem. Soc. 2014, 136, 16844– 16853[ ACS Full Text
], [ CAS], Google Scholar11https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVKmsLvJ&md5=16847a0fe13e510b4e0401d098d64371Immunogenicity study of Globo H analogues with modification at the reducing or nonreducing end of the tumor antigenLee, Hsin-Yu; Chen, Chien-Yu; Tsai, Tsung-I.; Li, Shiou-Ting; Lin, Kun-Hsien; Cheng, Yang-Yu; Ren, Chien-Tai; Cheng, Ting-Jen R.; Wu, Chung-Yi; Wong, Chi-HueyJournal of the American Chemical Society (2014), 136 (48), 16844-16853CODEN: JACSAT; ISSN:0002-7863. (American Chemical Society)Globo H-based therapeutic cancer vaccines have been tested in clin. trials for the treatment of late stage breast, ovarian, and prostate cancers. In this study, we explored Globo H analog antigens with an attempt to enhance the antigenic properties in vaccine design. The Globo H analogs with modification at the reducing or nonreducing end were synthesized using chemoenzymic methods, and these modified Globo H antigens were then conjugated with the carrier protein diphtheria toxoid cross-reactive material (CRM) 197 (DT), and combined with a glycolipid C34 as an adjuvant designed to induce a class switch to form the vaccine candidates. After Balb/c mice injection, the immune response was studied by a glycan array and the results showed that modification at the C-6 position of reducing end glucose of Globo H with the fluoro, azido, or Ph group elicited IgG antibody response to specifically recognize Globo H (GH) and the GH-related epitopes, stage-specific embryonic antigen 3 (SSEA3) (also called Gb5) and stage-specific embryonic antigen 4 (SSEA4). However, only the modification of Globo H with the azido group at the C-6 position of the nonreducing end fucose could elicit a strong IgG immune response. Moreover, the antibodies induced by these vaccines were shown to recognize GH expressing tumor cells (MCF-7) and mediate the complement-dependent cell cytotoxicity against tumor cells. Our data suggest a new potential approach to cancer vaccine development. - 12Orwenyo, J.; Huang, W.; Wang, L. X. Bioorg. Med. Chem. 2013, 21, 4768– 4777[ Crossref], [ PubMed], [ CAS], Google Scholar12https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsVKjt7o%253D&md5=ccd2ea3a7e341691242838a165fa0218Chemoenzymatic synthesis and lectin recognition of a selectively fluorinated glycoproteinOrwenyo, Jared; Huang, Wei; Wang, Lai-XiBioorganic & Medicinal Chemistry (2013), 21 (16), 4768-4777CODEN: BMECEP; ISSN:0968-0896. (Elsevier B.V.)A chemoenzymic glycosylation remodeling method for the synthesis of selectively fluorinated glycoproteins is described. The method consists of chem. synthesis of a fluoroglycan oxazoline and its use as donor substrate for endoglycosidase (ENGase)-catalyzed transglycosylation to a GlcNAc-protein to form a homogeneous fluoroglycoprotein. The approach was exemplified by the synthesis of fluorinated glycoforms of RNase B. An interesting finding was that fluorination at the C-6 of the 6-branched mannose moiety in the Man3GlcNAc core resulted in significantly enhanced reactivity of the substrate in enzymic transglycosylation. A structural anal. suggests that the enhancement in reactivity may come from favorable hydrophobic interactions between the fluorine and a tyrosine residue in the catalytic site of the enzyme (Endo-A). SPR anal. of the binding of the fluorinated glycoproteins with lectin Con A (con A) revealed the importance of the 6-hydroxyl group on the α-1,6-branched mannose moiety in con A recognition. The present study establishes a facile method for prepn. of selectively fluorinated glycoproteins that can serve as valuable probes for elucidating specific carbohydrate-protein interactions.
- 13Fröhlich, R. F. G.; Schrank, E.; Zangger, K. Carbohydr. Res. 2012, 361, 100– 104[ Crossref], [ PubMed], [ CAS], Google Scholar13https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bptFChtg%253D%253D&md5=622f16fd0cee30f287ba44fff4d21a3d2,2,2-Trifluoroethyl 6-thio-β-D-glucopyranoside as a selective tag for cysteines in proteinsFrohlich Richard F G; Schrank Evelyne; Zangger KlausCarbohydrate research (2012), 361 (), 100-4 ISSN:.A synthetic route to a trifluoromethyl and thiol containing glucose derivative (2,2,2-trifluoroethyl 6-thio-β-D-glucopyranoside) is presented, which is based on microwave-assisted Fischer glycosylation under increased pressure. This water-soluble, neutral thiol-compound can be used to selectively introduce a fluorine probe for (19)F NMR spectroscopy on cysteines in proteins. It can be attached under mild conditions in an aqueous environment without the risk of denaturing the protein. This tag has been applied to determine the redox-state of two cysteine residues in a bacterial transcription activator. Qualitative information about the solvent accessibility can be obtained from F-19 solvent PREs.
- 14Boutureira, O.; Bernardes, G. J. L.; Fernández-González, M.; Anthony, D. C.; Davis, B. G. Angew. Chem., Int. Ed. 2012, 51, 1432– 1436[ Crossref], [ PubMed], [ CAS], Google Scholar14https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitVegsw%253D%253D&md5=2d183abedd5298ab09420005485ecf1cSelenenylsulfide-linked Homogeneous Glycopeptides and Glycoproteins: Synthesis of Human "Hepatic Se Metabolite A"Boutureira, Omar; Bernardes, Goncalo J. L.; Fernandez-Gonzalez, Marta; Anthony, Daniel C.; Davis, Benjamin G.Angewandte Chemie, International Edition (2012), 51 (6), 1432-1436, S1432/1-S1432/46CODEN: ACIEF5; ISSN:1433-7851. (Wiley-VCH Verlag GmbH & Co. KGaA)The authors present the synthesis of selenenylsulfide-linked (glycosyl-SeS-Cys) glycopeptides and glycoproteins using a Cys-specific selenylation protocol of cysteine moiety in peptides and proteins, resp. The first synthesis and full characterization of human hepatic Se metabolite A, 5, is also reported.
- 15Boutureira, O.; Bernardes, G. J. L.; D’Hooge, F.; Davis, B. G. Chem. Commun. 2011, 47, 10010– 10012[ Crossref], [ PubMed], [ CAS], Google Scholar15https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2htrrK&md5=1e4e04570c0d0df64792885d1e85b5d5Direct radiolabelling of proteins at cysteine using [18F]-fluorosugarsBoutureira, Omar; Bernardes, Goncalo J. L.; D'Hooge, Francois; Davis, Benjamin G.Chemical Communications (Cambridge, United Kingdom) (2011), 47 (36), 10010-10012CODEN: CHCOFS; ISSN:1359-7345. (Royal Society of Chemistry)A strategy for the site-specific attachment of 2-deoxy-2-fluorosugars to cysteine and dehydroalanine tagged proteins is reported. When combined with thionation of fluorosugars, such as the widely available 18F probe 2-deoxy-2-[18F]fluoroglucose ([18F]FDG), this methodol. allows fast and direct access to site-specific [18F]FDG-labeled proteins.
- 16Yang, F.; Zheng, X.-J.; Huo, C.-X.; Wang, Y.; Zhang, Y.; Ye, X.-S. ACS Chem. Biol. 2011, 6, 252– 259[ ACS Full Text
], [ CAS], Google Scholar16https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivFegtA%253D%253D&md5=2a6baa094d17f16a150ec82db3fdfa8bEnhancement of the Immunogenicity of Synthetic Carbohydrate Vaccines by Chemical Modifications of STn AntigenYang, Fan; Zheng, Xiu-Jing; Huo, Chang-Xin; Wang, Yue; Zhang, Ye; Ye, Xin-ShanACS Chemical Biology (2011), 6 (3), 252-259CODEN: ACBCCT; ISSN:1554-8929. (American Chemical Society)The abnormal glycans expressed on the surface of tumor cells, known as tumor-assocd. carbohydrate antigens, increase the chance to develop carbohydrate-based anticancer vaccines. However, carbohydrate antigens pose certain difficulties, and the major drawback is their weak immunogenicity. To tackle this problem, numerous structurally modified STn antigens were designed and synthesized in this work. These synthetic antigens were screened in vitro by using competitive ELISA method, and the antigens with pos. response were conjugated to the protein carrier for vaccination. The vaccination results on mice showed that some fluorine-contg. modifications on the STn antigen can significantly increase the anti-STn IgG titers and improve the ratios of anti-STn IgG/IgM. The antisera can recognize the tumor cells expressing the native STn antigen. - 17Boutureira, O.; D’Hooge, F.; Fernández-González, M.; Bernardes, G. J. L.; Sánchez-Navarro, M.; Koeppe, J. R.; Davis, B. G. Chem. Commun. 2010, 46, 8142– 8144[ Crossref], [ PubMed], [ CAS], Google Scholar17https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlentbvM&md5=e0047684173aba2d6adc8f4e6aea9606Fluoroglycoproteins: ready chemical site-selective incorporation of fluorosugars into proteinsBoutureira, Omar; D'Hooge, Francois; Fernandez-Gonzalez, Marta; Bernardes, Goncalo J. L.; Sanchez-Navarro, Macarena; Koeppe, Julia R.; Davis, Benjamin G.Chemical Communications (Cambridge, United Kingdom) (2010), 46 (43), 8142-8144CODEN: CHCOFS; ISSN:1359-7345. (Royal Society of Chemistry)A tag-and-modify strategy allows the practical synthesis of homogeneous fluorinated glyco-amino acids, peptides and proteins carrying a fluorine label in the sugar and allows access to first examples of directly radiolabeled ([18F]-glyco)proteins.
- 18Fernández-González, M.; Boutureira, O.; Bernardes, G. J. L.; Chalker, J. M.; Young, M. A.; Errey, J. C.; Davis, B. G. Chem. Sci. 2010, 1, 709– 715[ Crossref], [ CAS], Google Scholar18https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2nsLnE&md5=613c61342fa65cd1273e79866d7bead4Site-selective chemoenzymatic construction of synthetic glycoproteins using endoglycosidasesFernandez-Gonzalez, Marta; Boutureira, Omar; Bernardes, Goncalo J. L.; Chalker, Justin M.; Young, Matthew A.; Errey, James C.; Davis, Benjamin G.Chemical Science (2010), 1 (6), 709-715CODEN: CSHCCN; ISSN:2041-6520. (Royal Society of Chemistry)Combined chem. tagging followed by Endo-A catalyzed elongation allows access to homogeneous, elaborated glycoproteins. A survey of different linkages and sugars demonstrated not only that unnatural linkages can be tolerated but they can provide insight into the scope of Endo-A transglycosylation activity. S-linked GlcNAc-glycoproteins are useful substrates for Endo-A extensions and display enhanced stability to hydrolysis at exposed sites. O-CH2-triazole-linked GlcNAc-glycoproteins derived from azidohomoalanine-tagged protein precursors were found to be optimal at sterically demanding sites.
- 19Wuest, F.; Berndt, M.; Bergmann, R.; van den Hoff, J.; Pietzsch, J. Bioconjugate Chem. 2008, 19, 1202– 1210[ ACS Full Text
], [ CAS], Google Scholar19https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvFaku7w%253D&md5=6ee3d22029fac0968007fd2557855622Synthesis and Application of [18F]FDG-Maleimidehexyloxime ([18F]FDG-MHO): A [18F]FDG-Based Prosthetic Group for the Chemoselective 18F-Labeling of Peptides and ProteinsWuest, Frank; Berndt, Mathias; Bergmann, Ralf; van den Hoff, Joerg; Pietzsch, JensBioconjugate Chemistry (2008), 19 (6), 1202-1210CODEN: BCCHES; ISSN:1043-1802. (American Chemical Society)2-[18F]Fluoro-2-deoxy-D-glucose ([18F]FDG) as the most important PET radiotracer is available in almost every PET center. However, there are only very few examples using [18F]FDG as a building block for the synthesis of 18F-labeled compds. The present study describes the use of [18F]FDG as a building block for the synthesis of 18F-labeled peptides and proteins. [18F]FDG was converted into [18F]FDG-maleimidehexyloxime ([18F]FDG-MHO), a novel [18F]FDG-based prosthetic group for the mild and thiol group-specific 18F labeling of peptides and proteins. The reaction was performed at 100 °C for 15 min in a sealed vial contg. [18F]FDG and N-(6-aminoxy-hexyl)maleimide in 80% ethanol. [18F]FDG-MHO was obtained in 45-69% radiochem. yield (based upon [18F]FDG) after HPLC purifn. in a total synthesis time of 45 min. Chemoselective conjugation of [18F]FDG-MHO to thiol groups was investigated by the reaction with the tripeptide glutathione (GSH) and the single cysteine contg. protein annexin A5 (anxA5). Radiolabeled annexin A5 ([18F]FDG-MHO-anxA5) was obtained in 43-58% radiochem. yield (based upon [18F]FDG-MHO, n = 6), and [18F]FDG-MHO-anxA5 was used for a pilot small animal PET study to assess in vivo biodistribution and kinetics in a HT-29 murine xenograft model. - 20Adamo, R.; Nilo, A.; Castagner, B.; Boutureira, O.; Berti, F.; Bernardes, G. J. L. Chem. Sci. 2013, 4, 2995– 3008[ Crossref], [ PubMed], [ CAS], Google Scholar20https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVehs7jN&md5=eb09336f0a6302efb364de7539fd94a4Synthetically defined glycoprotein vaccines: current status and future directionsAdamo, Roberto; Nilo, Alberto; Castagner, Bastien; Boutureira, Omar; Berti, Francesco; Bernardes, Goncalo J. L.Chemical Science (2013), 4 (8), 2995-3008CODEN: CSHCCN; ISSN:2041-6520. (Royal Society of Chemistry)A review. Primary examples in vaccine design have shown good levels of carbohydrate-specific antibody generation when raised using extd. or fully synthetic capsular polysaccharide glycans covalently coupled to a protein carrier. Herein, the authors cover recent clin. developments of carbohydrate-based vaccines and describe how novel cutting-edge methodol. for the total synthesis of oligosaccharides and for the precise placement of carbohydrates at pre-detd. sites within a protein may be used to further improve the safety and efficacy of glycovaccines.
- 21Maschauer, S.; Prante, O. Biomed Res. Int. 2014, 2014,.
Article ID 214748
- 22Ribeiro Morais, G.; Falconer, R. A.; Santos, I. Eur. J. Org. Chem. 2013, 1401– 1414[ Crossref], [ CAS], Google Scholar22https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXisVKhsr0%253D&md5=dc1684a316e65dac04605efc38c55ba0Carbohydrate-Based Molecules for Molecular Imaging in Nuclear MedicineRibeiro Morais, Goreti; Falconer, Robert A.; Santos, IsabelEuropean Journal of Organic Chemistry (2013), 2013 (8), 1401-1414CODEN: EJOCFK; ISSN:1099-0690. (Wiley-VCH Verlag GmbH & Co. KGaA)This review covers published literature describing the synthesis of labeled carbohydrates for use in mol. imaging, with a particular focus on the use of nuclear techniques (PET, SPECT). Recent advances in the radiosynthesis of [18F]FDG (electrophilic vs. nucleophilic radiofluorinations), a PET radiotracer based on glucose and the most widely PET tracer currently in use for cancer and inflammatory disease diagnosis, is considered. The powerful impact of [18F]FDG in the clinic has prompted intensive research efforts into glucose-based radiotracers for PET and SPECT imaging. These achievements are also reviewed, along with the use of glycopeptides for nuclear mol. imaging. Finally, recent work on the radionuclide labeling of nucleosides and glycoconjugates is discussed.
- 23Jacobson, O.; Kiesewetter, D. O.; Chen, X. Bioconjugate Chem. 2015, 26, 1– 18[ ACS Full Text
], [ CAS], Google Scholar23https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVaru73F&md5=576901e532d9190f51d56dc52b6f937cFluorine-18 Radiochemistry, Labeling Strategies and Synthetic RoutesJacobson, Orit; Kiesewetter, Dale O.; Chen, XiaoyuanBioconjugate Chemistry (2015), 26 (1), 1-18CODEN: BCCHES; ISSN:1043-1802. (American Chemical Society)A review. Fluorine-18 is the most frequently used radioisotope in positron emission tomog. (PET) radiopharmaceuticals in both clin. and preclin. research. Its phys. and nuclear characteristics (97% β+ decay, 109.7 min half-life, 635 keV positron energy), along with high specific activity and ease of large scale prodn., make it an attractive nuclide for radiochem. labeling and mol. imaging. Versatile chem. including nucleophilic and electrophilic substitutions allows direct or indirect introduction of 18F into mols. of interest. The significant increase in 18F radiotracers for PET imaging accentuates the need for simple and efficient 18F-labeling procedures. In this review, we will describe the current radiosynthesis routes and strategies for 18F labeling of small mols. and biomols. - 24Ametamey, S. M.; Honer, M.; Schubiger, P. A. Chem. Rev. 2008, 108, 1501– 1516[ ACS Full Text
], [ CAS], Google Scholar24https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvFShtL0%253D&md5=513a2a8c8779c207122a8c23586fd016Molecular Imaging with PETAmetamey, Simon M.; Honer, Michael; Schubiger, Pius AugustChemical Reviews (Washington, DC, United States) (2008), 108 (5), 1501-1516CODEN: CHREAY; ISSN:0009-2665. (American Chemical Society)A review. - 25Tirotta, I.; Dichiarante, V.; Pigliacelli, C.; Cavallo, G.; Terraneo, G.; Bombelli, F. B.; Metrangolo, P.; Resnati, G. Chem. Rev. 2015, 115, 1106– 1129[ ACS Full Text
], [ CAS], Google Scholar25https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOgsr3K&md5=152ea1869a7fe2141b0d00eefca6410619F Magnetic Resonance Imaging (MRI): From Design of Materials to Clinical ApplicationsTirotta, Ilaria; Dichiarante, Valentina; Pigliacelli, Claudia; Cavallo, Gabriella; Terraneo, Giancarlo; Bombelli, Francesca Baldelli; Metrangolo, Pierangelo; Resnati, GiuseppeChemical Reviews (Washington, DC, United States) (2015), 115 (2), 1106-1129CODEN: CHREAY; ISSN:0009-2665. (American Chemical Society)A review. This paper review the design of 19F magnetic resonance imaging agents and their application. - 26Boutureira, O.; Bernardes, G. J. L. Chem. Rev. 2015, 115, 2174– 2195[ ACS Full Text
], [ CAS], Google Scholar26https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtV2nu7k%253D&md5=d21a5407a59a7e12346c16e5db75ab91Advances in Chemical Protein ModificationBoutureira, Omar; Bernardes, Goncalo J. L.Chemical Reviews (Washington, DC, United States) (2015), 115 (5), 2174-2195CODEN: CHREAY; ISSN:0009-2665. (American Chemical Society)A review. Transition metal-free and -mediated approaches are covered. - 27Carrière, D.; Meunier, S. J.; Tropper, F. D.; Cao, S.; Roy, R. J. Mol. Catal. A: Chem. 2000, 154, 9– 22[ Crossref], [ CAS], Google Scholar27https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXit1Wis7Y%253D&md5=a2864a17acf8ad14f4d5f6f5161e4982Phase transfer catalysis toward the synthesis of O-, S-, Se- and C-glycosidesCarriere, D.; Meunier, S. J.; Tropper, F. D.; Cao, S.; Roy, R.Journal of Molecular Catalysis A: Chemical (2000), 154 (1-2), 9-22CODEN: JMCCF2; ISSN:1381-1169. (Elsevier Science B.V.)Phase transfer catalysis (PTC) has been used for the synthesis of anomeric glycosyl derivs., which included O-, S-, Se- and C- glycosides. These various glycosyl derivs. have been stereospecifically obtained from glycosyl halides. These reactions proceeded in generally good yields, and were essentially complete within 3 h.
- 28Dax, K.; Albert, M.; Ortner, J.; Paul, B. J. Carbohydr. Res. 2000, 327, 47– 86[ Crossref], [ PubMed], [ CAS], Google Scholar28https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsVGrtbg%253D&md5=42564cc8dfba468051e8456a7eb55ed2Synthesis of deoxyfluoro sugars from carbohydrate precursorsDax, Karl; Albert, Martin; Ortner, Jorg; Paul, Bernhard J.Carbohydrate Research (2000), 327 (1-2), 47-86CODEN: CRBRAT; ISSN:0008-6215. (Elsevier Science Ltd.)A review with 80 refs. summarizing results obtained over the past decade concerning the introduction of the fluorine atom into carbohydrate mols., either by nucleophilic substitution or electrophilic addn. reactions.
- 29Meloncelli, P. J.; Martin, A. D.; Lowary, T. L. Carbohydr. Res. 2009, 344, 1110– 1122[ Crossref], [ PubMed], [ CAS], Google Scholar29https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtlKksb0%253D&md5=76708f5cfe3310691598c7498823a4b7Glycosyl iodides. History and recent advancesMeloncelli, Peter J.; Martin, Alan D.; Lowary, Todd L.Carbohydrate Research (2009), 344 (9), 1110-1122CODEN: CRBRAT; ISSN:0008-6215. (Elsevier Ltd.)A review with refs. The use of glycosyl iodides as an effective method for the prepn. of glycosides has had a recent resurgence in carbohydrate chem., despite its early roots in which these species were believed to be of limited use. Renewed interest in these species as glycosylating agents has been spurred by their demonstrated utility in the stereoselective prepn. of O-glycosides, and other glycosylic compds. This review provides a brief historical account followed by an examn. of the use of glycosyl iodides in the synthesis of oligosaccharides and other glycomimetics, including C-glycosylic compds., glycosyl azides and N-glycosides.
- 30Nakai, K.; Takagi, Y.; Tsuchiya, T. Carbohydr. Res. 1999, 316, 47– 57[ Crossref], [ PubMed], [ CAS], Google Scholar30https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktFKntrc%253D&md5=ffe9aeabd9cffa431a34bfcc037cf2fcSynthesis and antitumor activity of 7-O-[2,6-dideoxy-2-fluoro-5-C-(trifluoromethyl)-α-L-talopyranosyl]-daunomycinone and -adriamycinoneNakai, Ken; Takagi, Yasushi; Tsuchiya, TsutomuCarbohydrate Research (1999), 316 (1-4), 47-57CODEN: CRBRAT; ISSN:0008-6215. (Elsevier Science Ltd.)7-O-[2,6-Dideoxy-2-fluoro-5-C-(trifluoromethyl)-α-L-talopyranosyl]-daunomycinone and -adriamycinone have been prepd. by the coupling of 3,4-di-O-acetyl-2,6-dideoxy-2-fluoro-5-C-(trifluoromethyl)-α-L-talopyranosyl iodide with daunomycinone. The key steps in this synthesis are the regioselective fluorination of Me α-D-lyxopyranoside to give the 4-deoxy-4-fluoro-β-L-ribopyranoside and the C-trifluoromethylation of the aldehydo-L-ribose deriv. to give the 1,1,1-trifluoro-5-monofluoro-L-altritol deriv. Antitumor activities of the synthetic products were compared with those for the 2'-deoxy-2'-fluoro and 2',6'-dideoxy-5'-C-trifluoromethyl analogs.
- 31Premchandran, R. H.; Ogletree, M. L.; Fried, J. J. Org. Chem. 1993, 58, 5724– 5731[ ACS Full Text
], [ CAS], Google Scholar31https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXotlGg&md5=461f831779ac0a9ae10f16f0ca225293Synthesis of a thromboxane A2 receptor antagonist possessing the dioxabicycloheptane nucleus of TXA2Premchandran, Ramiya H.; Ogletree, M. L.; Fried, JosefJournal of Organic Chemistry (1993), 58 (21), 5724-31CODEN: JOCEAH; ISSN:0022-3263.The synthesis of the TXA2/PGH2 receptor antagonist I from the known chiral intermediate (-)-II is described. The crit. reaction is the inversion of C-5 in III by an intramol. cyclization reaction induced by nucleophilic reagents. The key intermediate IV was prepd. in 26.5% yield in five steps. Diastereoselectivity is high in all but one of the steps. I is a receptor antagonist devoid of agonist activity, which binds to the receptor with nanomolar affinity. These findings lend support to the view of single TXA2/PGH2 receptor. - 32Tsuchiya, T.; Takahashi, Y.; Endo, M.; Umezawa, S.; Umezawa, H. J. Carbohydr. Chem. 1985, 4, 587– 611[ Crossref], [ CAS], Google Scholar32https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xks1Srt7c%253D&md5=65e88b7c19b893f798edd2522f29084cSynthesis of 2',3'-dideoxy-2'-fluorokanamycin ATsuchiya, Tsutomu; Takahashi, Yoshiaki; Endo, Makoto; Umezawa, Sumio; Umezawa, HamaoJournal of Carbohydrate Chemistry (1985), 4 (4), 587-611CODEN: JCACDM; ISSN:0732-8303.2',3'-Dideoxy-2'-fluorokanamycin A (I) was prepd. by condensation of 6-azido-4-O-benzoyl-2,3,6-trideoxy-2-fluoro-α-D-ribo-hexopyranosyl bromide (II) and protected disaccharide III (Ts = tosyl). Me 4,6-O-benzylidene-3-deoxy-β-D-arabino-hexopyranoside prepd. from Me 4,6-O-benzylidene-3-chloro-3-deoxy-β-D-allo-hexopyranoside by oxidn. with pyridinium chlorochromate followed by redn. with Na2S2O4 was fluorinated with the DAST reagent to give Me 4,6-O-benzylidene-2,3-dideoxy-2-fluoro-β-D-ribo-hexopyranoside (IV). The structure of I was detd. by the 1H and 19F and shift-correlated 2D NMR spectra. Antibacterial activity of I was only slightly weaker than that of 3'-deoxykanamycin A.
- 33Boutureira, O.; Díaz, Y.; Matheu, M. I.; Castillón, S. Synthesis and reactivity of 2-deoxy-2-fluoroglycosyl iodides. Part of this work has been presented as a poster at the 23rd International Carbohydrate Symposium, Whistler, Canada, July 23–28, 2006; TUE-PS.6.Google ScholarThere is no corresponding record for this reference.
- 34Chu, C.-Y.; Lee, W.-D.; Li, W.; Hwang, C. K. PCT Int. Appl. WO 2009061894A1 20090514, 2009.Google ScholarThere is no corresponding record for this reference.
- 35Thiem, J.; Meyer, B. Chem. Ber. 1980, 113, 3075– 3085[ Crossref], [ CAS], Google Scholar35https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXktFyr&md5=17c3622d742dca6c94b7f2bbf198115eSyntheses with iodo- and bromotrimethylsilane in saccharide chemistryThiem, Joachim; Meyer, BerndChemische Berichte (1980), 113 (9), 3075-85CODEN: CHBEAM; ISSN:0009-2940.Reaction of Me3SiI with penta-O-acetylhexopyranoses or tetra-O-acetyl-2-deoxyhexopyranoses gave the corresponding glycosyl iodides and 2-deoxyglycosyl iodides, resp. Me glycosides reacted similarly, and lactose octaacetate gave hepta-O-acetyl-α-D-lactosyl iodide. Similar reactions with Me3SiBr gave the corresponding glycosyl bromides. By opening of epoxides with Me3SiI in the case of sterically fixed saccharide oxiranes the trans-diaxial, and in the case of more flexible derivs. predominantly the trans-diequatorial iodohydrins were obtained.
- 36Dabideen, D. R.; Gervay-Hague, J. Org. Lett. 2004, 6, 973– 975[ ACS Full Text
], [ CAS], Google Scholar36https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFGitLY%253D&md5=ed5476b1111e85bab6a7db134f939edcUnique Reactions of Glycosyl Iodides with Oxa- and Thiocycloalkane AcceptorsDabideen, Darrin R.; Gervay-Hague, JacquelynOrganic Letters (2004), 6 (6), 973-975CODEN: ORLEF7; ISSN:1523-7060. (American Chemical Society)Glucosyl-, galactosyl-, and mannosyl iodides efficiently react with strained oxacycloalkane acceptors to afford O-glycosides with high β-selectivity. The mechanism of ring opening was investigated by reacting mannosyl iodides with pure enantiomers of propylene oxide and styrene oxide. Competition expts. between three- and five-membered oxacycloalkanes were also investigated. Finally, β-thiomannosides were synthesized from thiocycloalkane acceptors. - 37Mukhopadhyay, B.; Kartha, K. P. R.; Russell, D. A.; Field, R. A. J. Org. Chem. 2004, 69, 7758– 7760[ ACS Full Text
], [ CAS], Google Scholar37https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvVahtbY%253D&md5=80222926c97254fbbe5f23572f1b472aStreamlined Synthesis of Per-O-acetylated Sugars, Glycosyl Iodides, or Thioglycosides from Unprotected Reducing SugarsMukhopadhyay, Balaram; Kartha, K. P. Ravindranathan; Russell, David A.; Field, Robert A.Journal of Organic Chemistry (2004), 69 (22), 7758-7760CODEN: JOCEAH; ISSN:0022-3263. (American Chemical Society)Solvent-free per-O-acetylation of sugars with stoichiometric acetic anhydride and catalytic iodine proceeds in high yield (90-99%) to give exclusively pyranose products as anomeric mixts. Without workup, subsequent anomeric substitution employing iodine in the presence of hexamethyldisilane (i.e., TMS-I generated in situ) gives the corresponding glycosyl iodides in 75-95% isolated yield. Alternatively, and without workup, further treatment with di-Me disulfide or thiol (ethanethiol or thiocresol) gives anomerically pure thioglycosides in more than 75% overall yield. - 38Chervin, S. M.; Abada, P.; Koreeda, M. Org. Lett. 2000, 2, 369– 372[ ACS Full Text
], [ CAS], Google Scholar38https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtlWntg%253D%253D&md5=a3c7a9822b71b197d826f45795a7e2deConvenient, in Situ Generation of Anhydrous Hydrogen Iodide for the Preparation of α-Glycosyl Iodides and Vicinal Iodohydrins and for the Catalysis of Ferrier GlycosylationChervin, Stephanie M.; Abada, Paolo; Koreeda, MasatoOrganic Letters (2000), 2 (3), 369-372CODEN: ORLEF7; ISSN:1523-7060. (American Chemical Society)Anhyd. hydrogen iodide is generated in situ by the reaction of solid iodine and a thiol. The HI thus generated has been employed for the efficient prepn. of α-glycosyl iodides and vicinal iodohydrins from the corresponding glycosyl acetates and epoxides, resp., and for Ferrier glycosylation of alcs. and thiols. - 39Kováč, P.; Yeh, H. J. C.; Glaudemans, C. P. J. Carbohydr. Res. 1987, 169, 23– 34[ Crossref], [ PubMed], [ CAS], Google Scholar39https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXktlyjurc%253D&md5=2333129324e97a2dec8430b855593614Synthesis and NMR spectra of methyl 2-deoxy-2-fluoro- and 3-deoxy-3-fluoro-α- and β-D-glucopyranosidesKovac, Pavol; Yeh, Herman J. C.; Glaudemans, P. J.Carbohydrate Research (1987), 169 (), 23-34CODEN: CRBRAT; ISSN:0008-6215.Me 3-deoxy-3-fluoro-α- and β-D-glucopyranosides and α- and β-D-glucofuranosides were prepd. by methanolysis of 3-deoxy-3-fluoro-1,2:5,6-di-O-isopropylidene-α-D-glucofuranose. Cryst. 3,4,6-tri-O-acetyl-2-deoxy-2-fluoro-α-D-glucopyranosyl chloride (I) and bromide were prepd. from 1,3,4,6-tetra-O-acetyl-2-deoxy-2-fluoro-β-D-glucopyranose (II). Reaction of I with MeOH under the conditions of both silver triflate- and silver perchlorate-catalyzed glycosylation showed remarkable lack of stereoselectivity for the α-glycoside, despite the presence at C-2 of the F presumably not capable of neighboring-group participation. Pure Me 2-deoxy-2-fluoro-α- and β-D-glucopyranosides were obtained by fractional crystn. from the mixt. formed by methanolysis of II. The structure of these substances as well as of several other derivs. of 2-deoxy-2-fluoro- and 3-deoxy-3-fluoro-D-glucose were verified by (1H, 13C, and 19F) NMR.
- 40Michalik, M.; Hein, M.; Frank, M. Carbohydr. Res. 2000, 327, 185– 218[ Crossref], [ PubMed], [ CAS], Google Scholar40https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsVGrurw%253D&md5=c76bc46ef2e5671931d224f77405c480NMR spectra of fluorinated carbohydratesMichalik, Manfred; Hein, Martin; Frank, MichaelCarbohydrate Research (2000), 327 (1-2), 185-218CODEN: CRBRAT; ISSN:0008-6215. (Elsevier Science Ltd.)A review with 206 refs. on recent advances in structural and conformational anal. of fluorinated carbohydrates by NMR spectroscopy. Characteristic 1H, 13C, and 19F NMR chem. shifts and coupling consts. for selected examples are given and the spectral data of a series of fluorinated carbohydrates were collected in continuation of the review of Csuk and Glanzer.
- 41Abronina, P. I.; Kachala, V. V.; Kononov, L. O. Carbohydr. Res. 2009, 344, 240– 244[ Crossref], [ PubMed], [ CAS], Google Scholar41https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFOk&md5=418cb81cc1a412e0490f23e274c6819aA novel synthesis of β-D-mannopyranosyl azide by phase transfer catalysisAbronina, Polina I.; Kachala, Vadim V.; Kononov, Leonid O.Carbohydrate Research (2009), 344 (2), 240-244CODEN: CRBRAT; ISSN:0008-6215. (Elsevier Ltd.)A simple stereoselective synthesis of per-O-benzoyl-β-D-mannopyranosyl azide from per-O-benzoyl-α-D-mannopyranosyl bromide using phase transfer catalysis was developed. The stereochem. at C-1 of the anomeric O-benzoylated α- and β-D-mannopyranosyl azides was unambiguously established using 2D NOESY NMR spectroscopy. Pure deprotected β-D-mannopyranosyl azide was prepd. by debenzoylation with sodium methoxide in methanol.
- 42Hale, K. J.; Hough, L.; Manaviazar, S.; Calabrese, A. Org. Lett. 2014, 16, 4838– 4841[ ACS Full Text
], [ CAS], Google Scholar42https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFCjt7nF&md5=9b508c2db4ef5695f3d0cd03fb8347bfAn Update of the Rules for Pyranoside Sulfonate DisplacementHale, Karl J.; Hough, Leslie; Manaviazar, Soraya; Calabrese, AndrewOrganic Letters (2014), 16 (18), 4838-4841CODEN: ORLEF7; ISSN:1523-7052. (American Chemical Society)The original 1967 Richardson-Hough rules for predicting SN2 displacement viability in carbohydrate sulfonate derivs. with external nucleophiles have now been updated. Not only do the original rules still hold, but the newly updated rules rationalize why O-triflates (trifluoromethanesulfonate esters) frequently allow many seemingly "disallowed" pyranosidic nucleophilic substitutions to proceed. The new guidelines, which are based on three decades of exptl. evidence, allow the feasibility of many pyranosidic O-triflate SN2 displacements to be gauged beforehand. - 43Gamblin, D. P.; Garnier, P.; Ward, S. J.; Oldham, N. J.; Fairbanks, A. J.; Davis, B. G. Org. Biomol. Chem. 2003, 1, 3642– 3644[ Crossref], [ PubMed], [ CAS], Google Scholar43https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotleiurY%253D&md5=510159c1a828a2747a4b6599408e8ff5Glycosyl phenylthiosulfonates (Glyco-PTS): novel reagents for glycoprotein synthesisGamblin, David P.; Garnier, Philippe; Ward, Sarah J.; Oldham, Neil J.; Fairbanks, Antony J.; Davis, Benjamin G.Organic & Biomolecular Chemistry (2003), 1 (21), 3642-3644CODEN: OBCRAK; ISSN:1477-0520. (Royal Society of Chemistry)Controlled site-selective glycosylation can be achieved by combining site-directed cysteine mutagenesis with chem. modification of the introduced thiol. A new class of more efficient chemoselective reagents, glycosyl phenylthiosulfonates, allow rapid glycosylations of representative simple thiols, peptides and proteins.
- 44Černý, I.; Novotný, P.; Drašar, P.; Havel, M.; Pacák, J. Collect. Czech. Chem. Commun. 1989, 54, 2775– 2783[ Crossref], [ CAS], Google Scholar44https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXksVWisbo%253D&md5=55f60855494d1d46282de9617741fb28Steroids. Part CCCXLVI. Glycosylation of steroids with silver silicate and 2-deoxy-2-fluoro-α-D-glucopyranosyl bromide triacetateCerny, Ivan; Novotny, Petr; Drasar, Pavel; Havel, Miroslav; Pacak, JosefCollection of Czechoslovak Chemical Communications (1989), 54 (10), 2775-83CODEN: CCCCAK; ISSN:0010-0765.Glycosylation with the title glycosyl bromide in 1,2-dichloroethane in the presence of silver silicate and mol. sieves afforded mixts. of 3,4,6-tri-O-acetyl-2-deoxy-2-fluoro-α- and β-D-glucopyranosides, derived from Et (20E)-3β-hydroxy-24-nor-5,20(22)-choladien-23-oate, (20E)-3β-hydroxy-5β-pregn-20-ene-21-carboxylate and digitoxigenin, in which the β-anomers predominated. Sepn. and deacetylation furnished the resp. 2-deoxy-2-fluoroglucosides.
- 45Rempel, B. P.; Withers, S. G. Org. Biomol. Chem. 2014, 12, 2592– 2595[ Crossref], [ PubMed], [ CAS], Google Scholar45https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFWrtrc%253D&md5=2d1d9c9bf85d3ff61c8410440153700aPhosphodiesters serve as potentially tunable aglycones for fluoro sugar inactivators of retaining β-glycosidasesRempel, B. P.; Withers, S. G.Organic & Biomolecular Chemistry (2014), 12 (16), 2592-2595CODEN: OBCRAK; ISSN:1477-0520. (Royal Society of Chemistry)2-Deoxy-2-fluoroglycosides bearing dibenzyl phosphate and phosphonate aglycons were synthesized and tested as covalent inactivators of several retaining α- and β-glycosidases. β-D-Gluco-, -manno- and -galacto-configured benzyl-benzylphosphonate derivs. efficiently inactivated β-gluco-, β-manno- and β-galactosidases, while α-gluco- and α-manno-configured phosphate and phosphonate derivs. served instead as slow substrates.
- 46Rempel, B. P.; Tropak, M. B.; Mahuran, D. J.; Withers, S. G. Angew. Chem., Int. Ed. 2011, 50, 10381– 10383[ Crossref], [ PubMed], [ CAS], Google Scholar46https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFKhs7nM&md5=d08ad271c63e2f6e2f7cd8fbbfbf6878Tailoring the Specificity and Reactivity of a Mechanism-Based Inactivator of Glucocerebrosidase for Potential Therapeutic ApplicationsRempel, Brian P.; Tropak, Michael B.; Mahuran, Don J.; Withers, Stephen G.Angewandte Chemie, International Edition (2011), 50 (44), 10381-10383, S10381/1-S10381/25CODEN: ACIEF5; ISSN:1433-7851. (Wiley-VCH Verlag GmbH & Co. KGaA)The development of a new class of fluorosugar glycosidase inactivators bearing tunable phosphorus-based leaving groups that react with lysosomal β-Glucocerebrosidase over 4000 times faster than 2-deoxy-2-fluoro-β-D-glucosyl fluoride, is reported.
- 47Logue, S. E.; Elgendy, M.; Martin, S. J. Nat. Protoc. 2009, 4, 1383– 1395[ Crossref], [ PubMed], [ CAS], Google Scholar47https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVygsbvL&md5=563471996f250299c82e6bacc0f7d741Expression, purification and use of recombinant annexin V for the detection of apoptotic cellsLogue, Susan E.; Elgendy, Mohamed; Martin, Seamus J.Nature Protocols (2009), 4 (9), 1383-1395CODEN: NPARDW; ISSN:1750-2799. (Nature Publishing Group)Apoptosis is a mode of programmed cell death that is widely used to eliminate cells during development, tissue homeostasis, infection or in response to injury. Alterations to the plasma membranes of apoptotic cells trigger recognition and engulfment of such cells by phagocytes. Measurement of plasma membrane phosphatidylserine externalization, using fluorescently labeled annexin V, is widely used for the detection of apoptotic cells. Here the authors describe protocols for bacterial expression, purifn. and FITC labeling of recombinant annexin V. By following the method outlined in this protocol, it is possible to produce milligram amts. of recombinant annexin V within 3 d. The authors also describe a method for the assessment of annexin V binding to cell populations by flow cytometry or fluorescence microscopy.
Cited By
This article is cited by 7 publications.
- Annabel Kitowski, Ester Jiménez-Moreno, Míriam Salvadó, Jordi Mestre, Sergio Castillón, Gonzalo Jiménez-Osés, Omar Boutureira, and Gonçalo J. L. Bernardes . Oxidative Activation of C–S Bonds with an Electropositive Nitrogen Promoter Enables Orthogonal Glycosylation of Alkyl over Phenyl Thioglycosides. Organic Letters 2017, 19 (19) , 5490-5493. DOI: 10.1021/acs.orglett.7b02886.
- Jian-She Zhu, Nicole E. McCormick, Shannon C. Timmons, and David L. Jakeman . Synthesis of α-Deoxymono and Difluorohexopyranosyl 1-Phosphates and Kinetic Evaluation with Thymidylyl- and Guanidylyltransferases. The Journal of Organic Chemistry 2016, 81 (19) , 8816-8825. DOI: 10.1021/acs.joc.6b01485.
- P. Mampuys, C. R. McElroy, J. H. Clark, R. V. A. Orru, B. U. W. Maes. Thiosulfonates as Emerging Reactants: Synthesis and Applications. Advanced Synthesis & Catalysis 2020, 362 (1) , 3-64. DOI: 10.1002/adsc.201900864.
- Chunlai Feng, Jin Wang, Qiujie Tang, Zijian Zhong, Shusen Qiao, Xingyu Liu, Can Chen, Aihua Zhou. One-pot synthesis of glycosyl phenylthiosulfonates from sulfinate, S and glycosyl bromides. Carbohydrate Research 2019, 471, 1-5. DOI: 10.1016/j.carres.2018.10.005.
- Raju Jannapu Reddy, Md. Waheed, Jangam Jagadesh Kumar. A straightforward and convenient synthesis of functionalized allyl thiosulfonates and allyl disulfanes. RSC Advances 2018, 8 (70) , 40446-40453. DOI: 10.1039/C8RA06938G.
- Nan Yan, Zhi-Wei Lei, Jia-Kun Su, Wei-Lin Liao, Xiang-Guo Hu. Ring opening of sugar-derived epoxides by TBAF/KHF 2 : An attractive alternative for the introduction of fluorine into the carbohydrate scaffold. Chinese Chemical Letters 2017, 28 (2) , 467-470. DOI: 10.1016/j.cclet.2016.10.006.
- Yong Zheng, Feng-Ling Qing, Yangen Huang, Xiu-Hua Xu. Tunable and Practical Synthesis of Thiosulfonates and Disulfides from Sulfonyl Chlorides in the Presence of Tetrabutylammonium Iodide. Advanced Synthesis & Catalysis 2016, 358 (21) , 3477-3481. DOI: 10.1002/adsc.201600633.
Abstract

Scheme 1
Scheme 1. General Strategies for the Preparation of 1-β-“Soft Nu”-2-deoxy-2-fluoroglycosides Using F+Scheme 2
Scheme 2. Phase-Transfer Catalyzed Reactions (PTC) for the Preparation of 7–12aaGeneral conditions: 2-F-α-pyranosyl halide (1 equiv), Nu (2 equiv), TBAHS (2 equiv) in 5:1 EtOAc–1 M Na2CO3 aq (0.04 M), rt, from 1 h up to 7 days unless otherwise indicated.
Determined by 19F NMR of the crude reaction mixture.
2-F-α-galactosyl bromide 2b (1 equiv), Nu (2 equiv), TBAB (2 equiv) in 3:2 CH2Cl2–5% NaOH aq (0.02 M), rt, 14–22 h.
2-F-α-galactosyl bromide 2b (2 equiv), estrone (1 equiv), 60% NaH in mineral oil (1.5 equiv) in dry 1,4-dioxane (0.08 M), rt, 24 h. Nu = nucleophile. TBAHS = tetrabutylammonium hydrogen sulfate. TBAB = tetrabutylammonium bromide.
Scheme 3
Scheme 3. Selective Chemical Protein Modification of Annexin V 13aaGeneral conditions: Annexin V 13 (1 mg mL–1) (1 equiv), 2-F-sugar reagent 10a,b (250 equiv) in 20 mM Tris HCl buffer (pH 8.0) and 10% CH3CN, rt, 1 h.
References
ARTICLE SECTIONSThis article references 47 other publications.
- 1Johannes, M.; Reindl, M.; Gerlitzki, B.; Schmitt, E.; Hoffmann-Röder, A. Beilstein J. Org. Chem. 2015, 11, 155– 161[ Crossref], [ PubMed], [ CAS], Google Scholar1https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1ylu78%253D&md5=025648c9b782957da623e355e822c2afSynthesis and biological evaluation of a novel MUC1 glycopeptide conjugate vaccine candidate comprising a 4'-deoxy-4'-fluoro-Thomsen-Friedenreich epitopeJohannes, Manuel; Reindl, Maximilian; Gerlitzki, Bastian; Schmitt, Edgar; Hoffmann-Roeder, AnjaBeilstein Journal of Organic Chemistry (2015), 11 (), 155-161/1-155-161/7, 7 pp.CODEN: BJOCBH; ISSN:1860-5397. (Beilstein-Institut zur Foerderung der Chemischen Wissenschaften)The development of selective anticancer vaccines that provide enhanced protection against tumor recurrence and metastasis has been the subject of intense research in the scientific community. The tumor-assocd. glycoprotein MUC1 represents a well-established target for cancer immunotherapy and has been used for the construction of various synthetic vaccine candidates. However, many of these vaccine prototypes suffer from an inherent low immunogenicity and are susceptible to rapid in vivo degrdn. To overcome these drawbacks, novel fluorinated MUC1 glycopeptide-BSA/TTox conjugate vaccines have been prepd. Immunization of mice with the 4'F-TF-MUC1-TTox conjugate resulted in strong immune responses overriding the natural tolerance against MUC1 and producing selective IgG antibodies that are cross-reactive with native MUC1 epitopes on MCF-7 human cancer cells.
- 2Lamandé-Langle, S.; Collet, C.; Hensienne, R.; Vala, C.; Chrétien, F.; Chapleur, Y.; Mohamadi, A.; Lacolley, P.; Regnault, V. Bioorg. Med. Chem. 2014, 22, 6672– 6683[ Crossref], [ PubMed], [ CAS], Google Scholar2https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslelsr3F&md5=386b0c006baac912d7c3e14cf9ce5e70'Click' glycosylation of peptides through cysteine propargylation and CuAACLamande-Langle, Sandrine; Collet, Charlotte; Hensienne, Raphael; Vala, Christine; Chretien, Francoise; Chapleur, Yves; Mohamadi, Amel; Lacolley, Patrick; Regnault, VeroniqueBioorganic & Medicinal Chemistry (2014), 22 (23), 6672-6683CODEN: BMECEP; ISSN:0968-0896. (Elsevier B.V.)'Click' glycosylation of cysteine-contg. peptides were carried out in good yield by copper(I)-catalyzed azide-alkyne cycloaddn. (CuAAC). For that peptides were functionalized though direct propargylation of the cysteine residue allowing their use in CuAAC with suitable free or protected azido sugars of gluco, manno and galacto configuration. Among these free and protected glycopeptides a series of 'glycoRGD' peptides were obtained and submitted to in vitro platelet aggregation tests, showing that the pseudoglycosylation of the adhesion sequence lowers the IC50 value and thus could improve the in vivo pharmacokinetic properties.
- 3Dall’Angelo, S.; Zhang, Q.; Fleming, I. N.; Piras, M.; Schweiger, L. F.; O’Hagan, D.; Zanda, M. Org. Biomol. Chem. 2013, 11, 4551– 4558[ Crossref], [ PubMed], [ CAS], Google Scholar3https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpslClu7o%253D&md5=d09717a40cdbccedca2901a12c23c3d8Efficient bioconjugation of 5-fluoro-5-deoxy-ribose (FDR) to RGD peptides for positron emission tomography (PET) imaging of αvβ3 integrin receptorDall'Angelo, Sergio; Zhang, Qingzhi; Fleming, Ian N.; Piras, Monica; Schweiger, Lutz F.; O'Hagan, David; Zanda, MatteoOrganic & Biomolecular Chemistry (2013), 11 (27), 4551-4558CODEN: OBCRAK; ISSN:1477-0520. (Royal Society of Chemistry)The utility of 5-fluoro-5-deoxyribose (FDR) as an efficient bioconjugation agent for radiolabelling of the RGD peptides c(RGDfK) and c(RGDfC) is demonstrated. The bioconjugation is significantly superior to that achieved with 2-fluoro-2-deoxyglucose (FDG) and benefits from the location of the fluorine at C-5, and that ribose is a 5-membered ring sugar rather than a 6-membered ring. Both features favor ring opening to the aldehydic form of the sugar to promote smooth oxime ligation with aminooxy ether functionalised peptides. [18F]FDR was prepd. in this study by synthesis from fluoride-18 using an automated synthesis protocol adapting that used routinely for [18F]FDG. c(RGDfK) was functionalised with an aminooxyacetyl group (Aoa) via its lysine terminus, while c(RGDfC) was functionalised with an aminooxyhexylmaleimide (Ahm) through a cysteine-maleimide conjugation. Bioconjugation of [18F]FDR to c(RGDfC)-Ahm proved to be more efficient than c(RGDfK)-Aoa (92% vs. 65%). The unlabeled (19F) bioconjugates c(RGDfK)-Aoa-FDR and c(RGDfC)-Ahm-FDR were prepd. and their in vitro affinity to purified integrin αvβ3 was detd. c(RGDfK)-Aoa-FDR showed the greater affinity. Purified "hot" bioconjugates c(RGDfK)-Aoa-[18F]FDR and c(RGDfC)-Ahm-[18F]FDR were assayed by incubation with MCF7, LNCaP and PC3 cell lines. In both cases the conjugated RGD peptides showed selectivity for PC3 cells, which express αvβ3 integrin, with the c(RGDfK)-Aoa-[18F]FDR demonstrating better binding, consistent with its higher in vitro affinity. The study demonstrates that [18F]FDR is an efficient bioconjugation ligand for RGD bioactive peptides.
- 4Lang, C.; Maschauer, S.; Hübner, H.; Gmeiner, P.; Prante, O. J. Med. Chem. 2013, 56, 9361– 9365[ ACS Full Text
], [ CAS], Google Scholar4https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1yls7vJ&md5=baada842eccd8ae5393195087322d294Synthesis and Evaluation of a 18F-Labeled Diarylpyrazole Glycoconjugate for the Imaging of NTS1-Positive TumorsLang, Christopher; Maschauer, Simone; Huebner, Harald; Gmeiner, Peter; Prante, OlafJournal of Medicinal Chemistry (2013), 56 (22), 9361-9365CODEN: JMCMAR; ISSN:0022-2623. (American Chemical Society)Aiming to image NTS1 over-expressing tumors, the diarylpyrazole glycoconjugate I, derived from the potent NTS1 antagonist, was synthesized taking advantage of the palladium-catalyzed aminocarbonylation reaction. The glycoconjugate I displayed excellent affinity and selectivity toward NTS1. Radio-synthesis proceeded straightforwardly, obtaining [18F]-I with excellent stability and highly beneficial bio-distribution in vivo as demonstrated by PET imaging in HT29 tumor-bearing nude mice. Thus, the tracer [18F]-I represents a highly promising candidate for PET imaging of NTS1-pos. tumors. - 5Li, X.-G.; Dall’Angelo, S.; Schweiger, L. F.; Zanda, M.; O’Hagan, D. Chem. Commun. 2012, 48, 5247– 5249[ Crossref], [ PubMed], [ CAS], Google Scholar5https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtlOqsro%253D&md5=976a5461412c6d2a0f6ef0ae28c55d97[18F]-5-Fluoro-5-deoxyribose, an efficient peptide bioconjugation ligand for positron emission tomography (PET) imagingLi, Xiang-Guo; Dall'Angelo, Sergio; Schweiger, Lutz F.; Zanda, Matteo; O'Hagan, DavidChemical Communications (Cambridge, United Kingdom) (2012), 48 (43), 5247-5249CODEN: CHCOFS; ISSN:1359-7345. (Royal Society of Chemistry)[18F]-5-Fluoro-5-deoxyribose ([18F]-FDR) conjugates much more rapidly than [18F]-FDG under mild reaction conditions to peptides and offers new prospects for mild and rapid bioconjugation for fluorine-18 labeling in PET imaging.
- 6Maschauer, S.; Einsiedel, J.; Haubner, R.; Hocke, C.; Ocker, M.; Hübner, H.; Kuwert, T.; Gmeiner, P.; Prante, O. Angew. Chem., Int. Ed. 2010, 49, 976– 979[ Crossref], [ PubMed], [ CAS], Google Scholar6https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGmt7Y%253D&md5=c9dcd492a63cbbfe1c0542d95abaa6d8Labeling and Glycosylation of Peptides Using Click Chemistry: A General Approach to 18F-Glycopeptides as Effective Imaging Probes for Positron Emission TomographyMaschauer, Simone; Einsiedel, Juergen; Haubner, Roland; Hocke, Carsten; Ocker, Matthias; Huebner, Harald; Kuwert, Torsten; Gmeiner, Peter; Prante, OlafAngewandte Chemie, International Edition (2010), 49 (5), 976-979, S976/1-S976/18CODEN: ACIEF5; ISSN:1433-7851. (Wiley-VCH Verlag GmbH & Co. KGaA)Click chem. was used for 18F-labeling of glycopeptides for potential use as PET imaging agents.
- 7Hoffmann-Röder, A.; Kaiser, A.; Wagner, S.; Gaidzik, N.; Kowalczyk, D.; Westerlind, U.; Gerlitzki, B.; Schmitt, E.; Kunz, H. Angew. Chem., Int. Ed. 2010, 49, 8498– 8503[ Crossref], [ PubMed], [ CAS], Google Scholar7https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbis1CqtQ%253D%253D&md5=4ad8b8617c3c506d049a1ea8bdffe216Synthetic antitumor vaccines from tetanus toxoid conjugates of MUC1 glycopeptides with the Thomsen-Friedenreich antigen and a fluorine-substituted analogueHoffmann-Roder Anja; Kaiser Anton; Wagner Sarah; Gaidzik Nikola; Kowalczyk Danuta; Westerlind Ulrika; Gerlitzki Bastian; Schmitt Edgar; Kunz HorstAngewandte Chemie (International ed. in English) (2010), 49 (45), 8498-503 ISSN:.There is no expanded citation for this reference.
- 8Wuest, F.; Hultsch, C.; Berndt, M.; Bergmann, R. Bioorg. Med. Chem. Lett. 2009, 19, 5426– 5428[ Crossref], [ PubMed], [ CAS], Google Scholar8https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVeqsLvO&md5=a2b2972f5c6b3dfe917fbdf9259c673cDirect labelling of peptides with 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG)Wuest, Frank; Hultsch, Christina; Berndt, Mathias; Bergmann, RalfBioorganic & Medicinal Chemistry Letters (2009), 19 (18), 5426-5428CODEN: BMCLE8; ISSN:0960-894X. (Elsevier B.V.)The study describes the use of [18F]FDG as 18F building block for the direct labeling of various aminooxy-functionalised peptides via chemoselective oxime formation.
- 9Prante, O.; Einsiedel, J.; Haubner, R.; Gmeiner, P.; Wester, H.-J.; Kuwert, T.; Maschauer, S. Bioconjugate Chem. 2007, 18, 254– 262[ ACS Full Text
], [ CAS], Google Scholar9https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCgs7%252FE&md5=6db694427f3a27454386048a4c965e113,4,6-Tri-O-acetyl-2-deoxy-2-[18F]fluoroglucopyranosyl Phenylthiosulfonate: A Thiol-Reactive Agent for the Chemoselective 18F-Glycosylation of PeptidesPrante, Olaf; Einsiedel, Juergen; Haubner, Roland; Gmeiner, Peter; Wester, Hans-Juergen; Kuwert, Torsten; Maschauer, SimoneBioconjugate Chemistry (2007), 18 (1), 254-262CODEN: BCCHES; ISSN:1043-1802. (American Chemical Society)3,4,5-Tri-O-acetyl-2-[18F]fluoro-2-deoxy-D-glucopyranosyl 1-phenylthiosulfonate (I) was developed as a thiol-reactive labeling reagent for the site-specific 18F-glycosylation of peptides. Starting from 1,3,4,6-tetra-O-acetyl-2-deoxy-2-[18F]fluoroglucopyranose, a three-step radiochem. pathway was investigated and optimized, and I was obtained in a radiochem. yield of about 33% in 90 min (decay-cor. and based on starting [18F]fluoride). I was reacted with the model pentapeptide CAKAY, providing chemoselectivity and excellent conjugation yields of >90% under mild reaction conditions. The optimized method was adopted to the 18F-glycosylation of the αvβ3-affine peptide cyclo(RGDfC), achieving high conjugation yields (95%, decay-cor.). The αvβ3 binding affinity of the glycosylated cyclo(RGDfC) remained uninfluenced as detd. by competition binding studies vs. 125I-echistatin using both isolated αvβ3 and human umbilical vein endothelial cells (Ki = 68 ± 10 nM (αvβ3) vs. Ki = 77 ± 4 nM (HUVEC)). The whole radiosynthetic procedure, including the prepn. of I, peptide ligation, and final HPLC purifn., provided a decay-uncorrected radiochem. yield of 13% after a total synthesis time of 130 min. I can be used to prep. 18F-labeled bioactive S-glycopeptides for studying their pharmacokinetics in vivo by positron emission tomog. (PET). - 10Huo, C.-X.; Zheng, X.-J.; Xiao, A.; Liu, C.-C.; Sun, S.; Lv, Z.; Ye, X.-S. Org. Biomol. Chem. 2015, 13, 3677– 3690[ Crossref], [ PubMed], [ CAS], Google Scholar10https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2qtLY%253D&md5=dccf9199a88d330bdb4678ad4c6ad018Synthetic and immunological studies of N-acyl modified S-linked STn derivatives as anticancer vaccine candidatesHuo, Chang-Xin; Zheng, Xiu-Jing; Xiao, An; Liu, Chang-Cheng; Sun, Shuang; Lv, Zhuo; Ye, Xin-ShanOrganic & Biomolecular Chemistry (2015), 13 (12), 3677-3690CODEN: OBCRAK; ISSN:1477-0520. (Royal Society of Chemistry)It is well known that tumor cells express some aberrant glycans, termed tumor-assocd. carbohydrate antigens (TACAs). TACAs are good targets for the development of carbohydrate-based anticancer vaccines. However, one of the major problems is that carbohydrate antigens possess a weak immunogenicity. To tackle this problem, a no. of unnatural N-modified S-linked STn analogs were designed and prepd. Reaction of the modified STn disaccharides with bifunctional adipic acid p-nitrophenyl diester provided the corresponding activated esters, which was followed by the conjugation with keyhole limpet hemocyanin (KLH), affording the corresponding protein conjugates. The immunol. properties of these glycoconjugates were evaluated in a mouse model. The results showed that the modified glycoconjugates stimulated the prodn. of IgG antibodies that are capable of recognizing the naturally occurring STn antigen, helping the discovery of carbohydrate-based anticancer vaccine candidates.
- 11Lee, H.-Y.; Chen, C.-Y.; Tsai, T.-I.; Li, S.-T.; Lin, K.-H.; Cheng, Y.-Y.; Ren, C.-T.; Cheng, T.-J. R.; Wu, C.-Y.; Wong, C.-H. J. Am. Chem. Soc. 2014, 136, 16844– 16853[ ACS Full Text
], [ CAS], Google Scholar11https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVKmsLvJ&md5=16847a0fe13e510b4e0401d098d64371Immunogenicity study of Globo H analogues with modification at the reducing or nonreducing end of the tumor antigenLee, Hsin-Yu; Chen, Chien-Yu; Tsai, Tsung-I.; Li, Shiou-Ting; Lin, Kun-Hsien; Cheng, Yang-Yu; Ren, Chien-Tai; Cheng, Ting-Jen R.; Wu, Chung-Yi; Wong, Chi-HueyJournal of the American Chemical Society (2014), 136 (48), 16844-16853CODEN: JACSAT; ISSN:0002-7863. (American Chemical Society)Globo H-based therapeutic cancer vaccines have been tested in clin. trials for the treatment of late stage breast, ovarian, and prostate cancers. In this study, we explored Globo H analog antigens with an attempt to enhance the antigenic properties in vaccine design. The Globo H analogs with modification at the reducing or nonreducing end were synthesized using chemoenzymic methods, and these modified Globo H antigens were then conjugated with the carrier protein diphtheria toxoid cross-reactive material (CRM) 197 (DT), and combined with a glycolipid C34 as an adjuvant designed to induce a class switch to form the vaccine candidates. After Balb/c mice injection, the immune response was studied by a glycan array and the results showed that modification at the C-6 position of reducing end glucose of Globo H with the fluoro, azido, or Ph group elicited IgG antibody response to specifically recognize Globo H (GH) and the GH-related epitopes, stage-specific embryonic antigen 3 (SSEA3) (also called Gb5) and stage-specific embryonic antigen 4 (SSEA4). However, only the modification of Globo H with the azido group at the C-6 position of the nonreducing end fucose could elicit a strong IgG immune response. Moreover, the antibodies induced by these vaccines were shown to recognize GH expressing tumor cells (MCF-7) and mediate the complement-dependent cell cytotoxicity against tumor cells. Our data suggest a new potential approach to cancer vaccine development. - 12Orwenyo, J.; Huang, W.; Wang, L. X. Bioorg. Med. Chem. 2013, 21, 4768– 4777[ Crossref], [ PubMed], [ CAS], Google Scholar12https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsVKjt7o%253D&md5=ccd2ea3a7e341691242838a165fa0218Chemoenzymatic synthesis and lectin recognition of a selectively fluorinated glycoproteinOrwenyo, Jared; Huang, Wei; Wang, Lai-XiBioorganic & Medicinal Chemistry (2013), 21 (16), 4768-4777CODEN: BMECEP; ISSN:0968-0896. (Elsevier B.V.)A chemoenzymic glycosylation remodeling method for the synthesis of selectively fluorinated glycoproteins is described. The method consists of chem. synthesis of a fluoroglycan oxazoline and its use as donor substrate for endoglycosidase (ENGase)-catalyzed transglycosylation to a GlcNAc-protein to form a homogeneous fluoroglycoprotein. The approach was exemplified by the synthesis of fluorinated glycoforms of RNase B. An interesting finding was that fluorination at the C-6 of the 6-branched mannose moiety in the Man3GlcNAc core resulted in significantly enhanced reactivity of the substrate in enzymic transglycosylation. A structural anal. suggests that the enhancement in reactivity may come from favorable hydrophobic interactions between the fluorine and a tyrosine residue in the catalytic site of the enzyme (Endo-A). SPR anal. of the binding of the fluorinated glycoproteins with lectin Con A (con A) revealed the importance of the 6-hydroxyl group on the α-1,6-branched mannose moiety in con A recognition. The present study establishes a facile method for prepn. of selectively fluorinated glycoproteins that can serve as valuable probes for elucidating specific carbohydrate-protein interactions.
- 13Fröhlich, R. F. G.; Schrank, E.; Zangger, K. Carbohydr. Res. 2012, 361, 100– 104[ Crossref], [ PubMed], [ CAS], Google Scholar13https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bptFChtg%253D%253D&md5=622f16fd0cee30f287ba44fff4d21a3d2,2,2-Trifluoroethyl 6-thio-β-D-glucopyranoside as a selective tag for cysteines in proteinsFrohlich Richard F G; Schrank Evelyne; Zangger KlausCarbohydrate research (2012), 361 (), 100-4 ISSN:.A synthetic route to a trifluoromethyl and thiol containing glucose derivative (2,2,2-trifluoroethyl 6-thio-β-D-glucopyranoside) is presented, which is based on microwave-assisted Fischer glycosylation under increased pressure. This water-soluble, neutral thiol-compound can be used to selectively introduce a fluorine probe for (19)F NMR spectroscopy on cysteines in proteins. It can be attached under mild conditions in an aqueous environment without the risk of denaturing the protein. This tag has been applied to determine the redox-state of two cysteine residues in a bacterial transcription activator. Qualitative information about the solvent accessibility can be obtained from F-19 solvent PREs.
- 14Boutureira, O.; Bernardes, G. J. L.; Fernández-González, M.; Anthony, D. C.; Davis, B. G. Angew. Chem., Int. Ed. 2012, 51, 1432– 1436[ Crossref], [ PubMed], [ CAS], Google Scholar14https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitVegsw%253D%253D&md5=2d183abedd5298ab09420005485ecf1cSelenenylsulfide-linked Homogeneous Glycopeptides and Glycoproteins: Synthesis of Human "Hepatic Se Metabolite A"Boutureira, Omar; Bernardes, Goncalo J. L.; Fernandez-Gonzalez, Marta; Anthony, Daniel C.; Davis, Benjamin G.Angewandte Chemie, International Edition (2012), 51 (6), 1432-1436, S1432/1-S1432/46CODEN: ACIEF5; ISSN:1433-7851. (Wiley-VCH Verlag GmbH & Co. KGaA)The authors present the synthesis of selenenylsulfide-linked (glycosyl-SeS-Cys) glycopeptides and glycoproteins using a Cys-specific selenylation protocol of cysteine moiety in peptides and proteins, resp. The first synthesis and full characterization of human hepatic Se metabolite A, 5, is also reported.
- 15Boutureira, O.; Bernardes, G. J. L.; D’Hooge, F.; Davis, B. G. Chem. Commun. 2011, 47, 10010– 10012[ Crossref], [ PubMed], [ CAS], Google Scholar15https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2htrrK&md5=1e4e04570c0d0df64792885d1e85b5d5Direct radiolabelling of proteins at cysteine using [18F]-fluorosugarsBoutureira, Omar; Bernardes, Goncalo J. L.; D'Hooge, Francois; Davis, Benjamin G.Chemical Communications (Cambridge, United Kingdom) (2011), 47 (36), 10010-10012CODEN: CHCOFS; ISSN:1359-7345. (Royal Society of Chemistry)A strategy for the site-specific attachment of 2-deoxy-2-fluorosugars to cysteine and dehydroalanine tagged proteins is reported. When combined with thionation of fluorosugars, such as the widely available 18F probe 2-deoxy-2-[18F]fluoroglucose ([18F]FDG), this methodol. allows fast and direct access to site-specific [18F]FDG-labeled proteins.
- 16Yang, F.; Zheng, X.-J.; Huo, C.-X.; Wang, Y.; Zhang, Y.; Ye, X.-S. ACS Chem. Biol. 2011, 6, 252– 259[ ACS Full Text
], [ CAS], Google Scholar16https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivFegtA%253D%253D&md5=2a6baa094d17f16a150ec82db3fdfa8bEnhancement of the Immunogenicity of Synthetic Carbohydrate Vaccines by Chemical Modifications of STn AntigenYang, Fan; Zheng, Xiu-Jing; Huo, Chang-Xin; Wang, Yue; Zhang, Ye; Ye, Xin-ShanACS Chemical Biology (2011), 6 (3), 252-259CODEN: ACBCCT; ISSN:1554-8929. (American Chemical Society)The abnormal glycans expressed on the surface of tumor cells, known as tumor-assocd. carbohydrate antigens, increase the chance to develop carbohydrate-based anticancer vaccines. However, carbohydrate antigens pose certain difficulties, and the major drawback is their weak immunogenicity. To tackle this problem, numerous structurally modified STn antigens were designed and synthesized in this work. These synthetic antigens were screened in vitro by using competitive ELISA method, and the antigens with pos. response were conjugated to the protein carrier for vaccination. The vaccination results on mice showed that some fluorine-contg. modifications on the STn antigen can significantly increase the anti-STn IgG titers and improve the ratios of anti-STn IgG/IgM. The antisera can recognize the tumor cells expressing the native STn antigen. - 17Boutureira, O.; D’Hooge, F.; Fernández-González, M.; Bernardes, G. J. L.; Sánchez-Navarro, M.; Koeppe, J. R.; Davis, B. G. Chem. Commun. 2010, 46, 8142– 8144[ Crossref], [ PubMed], [ CAS], Google Scholar17https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlentbvM&md5=e0047684173aba2d6adc8f4e6aea9606Fluoroglycoproteins: ready chemical site-selective incorporation of fluorosugars into proteinsBoutureira, Omar; D'Hooge, Francois; Fernandez-Gonzalez, Marta; Bernardes, Goncalo J. L.; Sanchez-Navarro, Macarena; Koeppe, Julia R.; Davis, Benjamin G.Chemical Communications (Cambridge, United Kingdom) (2010), 46 (43), 8142-8144CODEN: CHCOFS; ISSN:1359-7345. (Royal Society of Chemistry)A tag-and-modify strategy allows the practical synthesis of homogeneous fluorinated glyco-amino acids, peptides and proteins carrying a fluorine label in the sugar and allows access to first examples of directly radiolabeled ([18F]-glyco)proteins.
- 18Fernández-González, M.; Boutureira, O.; Bernardes, G. J. L.; Chalker, J. M.; Young, M. A.; Errey, J. C.; Davis, B. G. Chem. Sci. 2010, 1, 709– 715[ Crossref], [ CAS], Google Scholar18https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2nsLnE&md5=613c61342fa65cd1273e79866d7bead4Site-selective chemoenzymatic construction of synthetic glycoproteins using endoglycosidasesFernandez-Gonzalez, Marta; Boutureira, Omar; Bernardes, Goncalo J. L.; Chalker, Justin M.; Young, Matthew A.; Errey, James C.; Davis, Benjamin G.Chemical Science (2010), 1 (6), 709-715CODEN: CSHCCN; ISSN:2041-6520. (Royal Society of Chemistry)Combined chem. tagging followed by Endo-A catalyzed elongation allows access to homogeneous, elaborated glycoproteins. A survey of different linkages and sugars demonstrated not only that unnatural linkages can be tolerated but they can provide insight into the scope of Endo-A transglycosylation activity. S-linked GlcNAc-glycoproteins are useful substrates for Endo-A extensions and display enhanced stability to hydrolysis at exposed sites. O-CH2-triazole-linked GlcNAc-glycoproteins derived from azidohomoalanine-tagged protein precursors were found to be optimal at sterically demanding sites.
- 19Wuest, F.; Berndt, M.; Bergmann, R.; van den Hoff, J.; Pietzsch, J. Bioconjugate Chem. 2008, 19, 1202– 1210[ ACS Full Text
], [ CAS], Google Scholar19https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvFaku7w%253D&md5=6ee3d22029fac0968007fd2557855622Synthesis and Application of [18F]FDG-Maleimidehexyloxime ([18F]FDG-MHO): A [18F]FDG-Based Prosthetic Group for the Chemoselective 18F-Labeling of Peptides and ProteinsWuest, Frank; Berndt, Mathias; Bergmann, Ralf; van den Hoff, Joerg; Pietzsch, JensBioconjugate Chemistry (2008), 19 (6), 1202-1210CODEN: BCCHES; ISSN:1043-1802. (American Chemical Society)2-[18F]Fluoro-2-deoxy-D-glucose ([18F]FDG) as the most important PET radiotracer is available in almost every PET center. However, there are only very few examples using [18F]FDG as a building block for the synthesis of 18F-labeled compds. The present study describes the use of [18F]FDG as a building block for the synthesis of 18F-labeled peptides and proteins. [18F]FDG was converted into [18F]FDG-maleimidehexyloxime ([18F]FDG-MHO), a novel [18F]FDG-based prosthetic group for the mild and thiol group-specific 18F labeling of peptides and proteins. The reaction was performed at 100 °C for 15 min in a sealed vial contg. [18F]FDG and N-(6-aminoxy-hexyl)maleimide in 80% ethanol. [18F]FDG-MHO was obtained in 45-69% radiochem. yield (based upon [18F]FDG) after HPLC purifn. in a total synthesis time of 45 min. Chemoselective conjugation of [18F]FDG-MHO to thiol groups was investigated by the reaction with the tripeptide glutathione (GSH) and the single cysteine contg. protein annexin A5 (anxA5). Radiolabeled annexin A5 ([18F]FDG-MHO-anxA5) was obtained in 43-58% radiochem. yield (based upon [18F]FDG-MHO, n = 6), and [18F]FDG-MHO-anxA5 was used for a pilot small animal PET study to assess in vivo biodistribution and kinetics in a HT-29 murine xenograft model. - 20Adamo, R.; Nilo, A.; Castagner, B.; Boutureira, O.; Berti, F.; Bernardes, G. J. L. Chem. Sci. 2013, 4, 2995– 3008[ Crossref], [ PubMed], [ CAS], Google Scholar20https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVehs7jN&md5=eb09336f0a6302efb364de7539fd94a4Synthetically defined glycoprotein vaccines: current status and future directionsAdamo, Roberto; Nilo, Alberto; Castagner, Bastien; Boutureira, Omar; Berti, Francesco; Bernardes, Goncalo J. L.Chemical Science (2013), 4 (8), 2995-3008CODEN: CSHCCN; ISSN:2041-6520. (Royal Society of Chemistry)A review. Primary examples in vaccine design have shown good levels of carbohydrate-specific antibody generation when raised using extd. or fully synthetic capsular polysaccharide glycans covalently coupled to a protein carrier. Herein, the authors cover recent clin. developments of carbohydrate-based vaccines and describe how novel cutting-edge methodol. for the total synthesis of oligosaccharides and for the precise placement of carbohydrates at pre-detd. sites within a protein may be used to further improve the safety and efficacy of glycovaccines.
- 21Maschauer, S.; Prante, O. Biomed Res. Int. 2014, 2014,.
Article ID 214748
- 22Ribeiro Morais, G.; Falconer, R. A.; Santos, I. Eur. J. Org. Chem. 2013, 1401– 1414[ Crossref], [ CAS], Google Scholar22https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXisVKhsr0%253D&md5=dc1684a316e65dac04605efc38c55ba0Carbohydrate-Based Molecules for Molecular Imaging in Nuclear MedicineRibeiro Morais, Goreti; Falconer, Robert A.; Santos, IsabelEuropean Journal of Organic Chemistry (2013), 2013 (8), 1401-1414CODEN: EJOCFK; ISSN:1099-0690. (Wiley-VCH Verlag GmbH & Co. KGaA)This review covers published literature describing the synthesis of labeled carbohydrates for use in mol. imaging, with a particular focus on the use of nuclear techniques (PET, SPECT). Recent advances in the radiosynthesis of [18F]FDG (electrophilic vs. nucleophilic radiofluorinations), a PET radiotracer based on glucose and the most widely PET tracer currently in use for cancer and inflammatory disease diagnosis, is considered. The powerful impact of [18F]FDG in the clinic has prompted intensive research efforts into glucose-based radiotracers for PET and SPECT imaging. These achievements are also reviewed, along with the use of glycopeptides for nuclear mol. imaging. Finally, recent work on the radionuclide labeling of nucleosides and glycoconjugates is discussed.
- 23Jacobson, O.; Kiesewetter, D. O.; Chen, X. Bioconjugate Chem. 2015, 26, 1– 18[ ACS Full Text
], [ CAS], Google Scholar23https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVaru73F&md5=576901e532d9190f51d56dc52b6f937cFluorine-18 Radiochemistry, Labeling Strategies and Synthetic RoutesJacobson, Orit; Kiesewetter, Dale O.; Chen, XiaoyuanBioconjugate Chemistry (2015), 26 (1), 1-18CODEN: BCCHES; ISSN:1043-1802. (American Chemical Society)A review. Fluorine-18 is the most frequently used radioisotope in positron emission tomog. (PET) radiopharmaceuticals in both clin. and preclin. research. Its phys. and nuclear characteristics (97% β+ decay, 109.7 min half-life, 635 keV positron energy), along with high specific activity and ease of large scale prodn., make it an attractive nuclide for radiochem. labeling and mol. imaging. Versatile chem. including nucleophilic and electrophilic substitutions allows direct or indirect introduction of 18F into mols. of interest. The significant increase in 18F radiotracers for PET imaging accentuates the need for simple and efficient 18F-labeling procedures. In this review, we will describe the current radiosynthesis routes and strategies for 18F labeling of small mols. and biomols. - 24Ametamey, S. M.; Honer, M.; Schubiger, P. A. Chem. Rev. 2008, 108, 1501– 1516[ ACS Full Text
], [ CAS], Google Scholar24https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvFShtL0%253D&md5=513a2a8c8779c207122a8c23586fd016Molecular Imaging with PETAmetamey, Simon M.; Honer, Michael; Schubiger, Pius AugustChemical Reviews (Washington, DC, United States) (2008), 108 (5), 1501-1516CODEN: CHREAY; ISSN:0009-2665. (American Chemical Society)A review. - 25Tirotta, I.; Dichiarante, V.; Pigliacelli, C.; Cavallo, G.; Terraneo, G.; Bombelli, F. B.; Metrangolo, P.; Resnati, G. Chem. Rev. 2015, 115, 1106– 1129[ ACS Full Text
], [ CAS], Google Scholar25https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOgsr3K&md5=152ea1869a7fe2141b0d00eefca6410619F Magnetic Resonance Imaging (MRI): From Design of Materials to Clinical ApplicationsTirotta, Ilaria; Dichiarante, Valentina; Pigliacelli, Claudia; Cavallo, Gabriella; Terraneo, Giancarlo; Bombelli, Francesca Baldelli; Metrangolo, Pierangelo; Resnati, GiuseppeChemical Reviews (Washington, DC, United States) (2015), 115 (2), 1106-1129CODEN: CHREAY; ISSN:0009-2665. (American Chemical Society)A review. This paper review the design of 19F magnetic resonance imaging agents and their application. - 26Boutureira, O.; Bernardes, G. J. L. Chem. Rev. 2015, 115, 2174– 2195[ ACS Full Text
], [ CAS], Google Scholar26https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtV2nu7k%253D&md5=d21a5407a59a7e12346c16e5db75ab91Advances in Chemical Protein ModificationBoutureira, Omar; Bernardes, Goncalo J. L.Chemical Reviews (Washington, DC, United States) (2015), 115 (5), 2174-2195CODEN: CHREAY; ISSN:0009-2665. (American Chemical Society)A review. Transition metal-free and -mediated approaches are covered. - 27Carrière, D.; Meunier, S. J.; Tropper, F. D.; Cao, S.; Roy, R. J. Mol. Catal. A: Chem. 2000, 154, 9– 22[ Crossref], [ CAS], Google Scholar27https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXit1Wis7Y%253D&md5=a2864a17acf8ad14f4d5f6f5161e4982Phase transfer catalysis toward the synthesis of O-, S-, Se- and C-glycosidesCarriere, D.; Meunier, S. J.; Tropper, F. D.; Cao, S.; Roy, R.Journal of Molecular Catalysis A: Chemical (2000), 154 (1-2), 9-22CODEN: JMCCF2; ISSN:1381-1169. (Elsevier Science B.V.)Phase transfer catalysis (PTC) has been used for the synthesis of anomeric glycosyl derivs., which included O-, S-, Se- and C- glycosides. These various glycosyl derivs. have been stereospecifically obtained from glycosyl halides. These reactions proceeded in generally good yields, and were essentially complete within 3 h.
- 28Dax, K.; Albert, M.; Ortner, J.; Paul, B. J. Carbohydr. Res. 2000, 327, 47– 86[ Crossref], [ PubMed], [ CAS], Google Scholar28https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsVGrtbg%253D&md5=42564cc8dfba468051e8456a7eb55ed2Synthesis of deoxyfluoro sugars from carbohydrate precursorsDax, Karl; Albert, Martin; Ortner, Jorg; Paul, Bernhard J.Carbohydrate Research (2000), 327 (1-2), 47-86CODEN: CRBRAT; ISSN:0008-6215. (Elsevier Science Ltd.)A review with 80 refs. summarizing results obtained over the past decade concerning the introduction of the fluorine atom into carbohydrate mols., either by nucleophilic substitution or electrophilic addn. reactions.
- 29Meloncelli, P. J.; Martin, A. D.; Lowary, T. L. Carbohydr. Res. 2009, 344, 1110– 1122[ Crossref], [ PubMed], [ CAS], Google Scholar29https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtlKksb0%253D&md5=76708f5cfe3310691598c7498823a4b7Glycosyl iodides. History and recent advancesMeloncelli, Peter J.; Martin, Alan D.; Lowary, Todd L.Carbohydrate Research (2009), 344 (9), 1110-1122CODEN: CRBRAT; ISSN:0008-6215. (Elsevier Ltd.)A review with refs. The use of glycosyl iodides as an effective method for the prepn. of glycosides has had a recent resurgence in carbohydrate chem., despite its early roots in which these species were believed to be of limited use. Renewed interest in these species as glycosylating agents has been spurred by their demonstrated utility in the stereoselective prepn. of O-glycosides, and other glycosylic compds. This review provides a brief historical account followed by an examn. of the use of glycosyl iodides in the synthesis of oligosaccharides and other glycomimetics, including C-glycosylic compds., glycosyl azides and N-glycosides.
- 30Nakai, K.; Takagi, Y.; Tsuchiya, T. Carbohydr. Res. 1999, 316, 47– 57[ Crossref], [ PubMed], [ CAS], Google Scholar30https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktFKntrc%253D&md5=ffe9aeabd9cffa431a34bfcc037cf2fcSynthesis and antitumor activity of 7-O-[2,6-dideoxy-2-fluoro-5-C-(trifluoromethyl)-α-L-talopyranosyl]-daunomycinone and -adriamycinoneNakai, Ken; Takagi, Yasushi; Tsuchiya, TsutomuCarbohydrate Research (1999), 316 (1-4), 47-57CODEN: CRBRAT; ISSN:0008-6215. (Elsevier Science Ltd.)7-O-[2,6-Dideoxy-2-fluoro-5-C-(trifluoromethyl)-α-L-talopyranosyl]-daunomycinone and -adriamycinone have been prepd. by the coupling of 3,4-di-O-acetyl-2,6-dideoxy-2-fluoro-5-C-(trifluoromethyl)-α-L-talopyranosyl iodide with daunomycinone. The key steps in this synthesis are the regioselective fluorination of Me α-D-lyxopyranoside to give the 4-deoxy-4-fluoro-β-L-ribopyranoside and the C-trifluoromethylation of the aldehydo-L-ribose deriv. to give the 1,1,1-trifluoro-5-monofluoro-L-altritol deriv. Antitumor activities of the synthetic products were compared with those for the 2'-deoxy-2'-fluoro and 2',6'-dideoxy-5'-C-trifluoromethyl analogs.
- 31Premchandran, R. H.; Ogletree, M. L.; Fried, J. J. Org. Chem. 1993, 58, 5724– 5731[ ACS Full Text
], [ CAS], Google Scholar31https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXotlGg&md5=461f831779ac0a9ae10f16f0ca225293Synthesis of a thromboxane A2 receptor antagonist possessing the dioxabicycloheptane nucleus of TXA2Premchandran, Ramiya H.; Ogletree, M. L.; Fried, JosefJournal of Organic Chemistry (1993), 58 (21), 5724-31CODEN: JOCEAH; ISSN:0022-3263.The synthesis of the TXA2/PGH2 receptor antagonist I from the known chiral intermediate (-)-II is described. The crit. reaction is the inversion of C-5 in III by an intramol. cyclization reaction induced by nucleophilic reagents. The key intermediate IV was prepd. in 26.5% yield in five steps. Diastereoselectivity is high in all but one of the steps. I is a receptor antagonist devoid of agonist activity, which binds to the receptor with nanomolar affinity. These findings lend support to the view of single TXA2/PGH2 receptor. - 32Tsuchiya, T.; Takahashi, Y.; Endo, M.; Umezawa, S.; Umezawa, H. J. Carbohydr. Chem. 1985, 4, 587– 611[ Crossref], [ CAS], Google Scholar32https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xks1Srt7c%253D&md5=65e88b7c19b893f798edd2522f29084cSynthesis of 2',3'-dideoxy-2'-fluorokanamycin ATsuchiya, Tsutomu; Takahashi, Yoshiaki; Endo, Makoto; Umezawa, Sumio; Umezawa, HamaoJournal of Carbohydrate Chemistry (1985), 4 (4), 587-611CODEN: JCACDM; ISSN:0732-8303.2',3'-Dideoxy-2'-fluorokanamycin A (I) was prepd. by condensation of 6-azido-4-O-benzoyl-2,3,6-trideoxy-2-fluoro-α-D-ribo-hexopyranosyl bromide (II) and protected disaccharide III (Ts = tosyl). Me 4,6-O-benzylidene-3-deoxy-β-D-arabino-hexopyranoside prepd. from Me 4,6-O-benzylidene-3-chloro-3-deoxy-β-D-allo-hexopyranoside by oxidn. with pyridinium chlorochromate followed by redn. with Na2S2O4 was fluorinated with the DAST reagent to give Me 4,6-O-benzylidene-2,3-dideoxy-2-fluoro-β-D-ribo-hexopyranoside (IV). The structure of I was detd. by the 1H and 19F and shift-correlated 2D NMR spectra. Antibacterial activity of I was only slightly weaker than that of 3'-deoxykanamycin A.
- 33Boutureira, O.; Díaz, Y.; Matheu, M. I.; Castillón, S. Synthesis and reactivity of 2-deoxy-2-fluoroglycosyl iodides. Part of this work has been presented as a poster at the 23rd International Carbohydrate Symposium, Whistler, Canada, July 23–28, 2006; TUE-PS.6.Google ScholarThere is no corresponding record for this reference.
- 34Chu, C.-Y.; Lee, W.-D.; Li, W.; Hwang, C. K. PCT Int. Appl. WO 2009061894A1 20090514, 2009.Google ScholarThere is no corresponding record for this reference.
- 35Thiem, J.; Meyer, B. Chem. Ber. 1980, 113, 3075– 3085[ Crossref], [ CAS], Google Scholar35https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXktFyr&md5=17c3622d742dca6c94b7f2bbf198115eSyntheses with iodo- and bromotrimethylsilane in saccharide chemistryThiem, Joachim; Meyer, BerndChemische Berichte (1980), 113 (9), 3075-85CODEN: CHBEAM; ISSN:0009-2940.Reaction of Me3SiI with penta-O-acetylhexopyranoses or tetra-O-acetyl-2-deoxyhexopyranoses gave the corresponding glycosyl iodides and 2-deoxyglycosyl iodides, resp. Me glycosides reacted similarly, and lactose octaacetate gave hepta-O-acetyl-α-D-lactosyl iodide. Similar reactions with Me3SiBr gave the corresponding glycosyl bromides. By opening of epoxides with Me3SiI in the case of sterically fixed saccharide oxiranes the trans-diaxial, and in the case of more flexible derivs. predominantly the trans-diequatorial iodohydrins were obtained.
- 36Dabideen, D. R.; Gervay-Hague, J. Org. Lett. 2004, 6, 973– 975[ ACS Full Text
], [ CAS], Google Scholar36https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFGitLY%253D&md5=ed5476b1111e85bab6a7db134f939edcUnique Reactions of Glycosyl Iodides with Oxa- and Thiocycloalkane AcceptorsDabideen, Darrin R.; Gervay-Hague, JacquelynOrganic Letters (2004), 6 (6), 973-975CODEN: ORLEF7; ISSN:1523-7060. (American Chemical Society)Glucosyl-, galactosyl-, and mannosyl iodides efficiently react with strained oxacycloalkane acceptors to afford O-glycosides with high β-selectivity. The mechanism of ring opening was investigated by reacting mannosyl iodides with pure enantiomers of propylene oxide and styrene oxide. Competition expts. between three- and five-membered oxacycloalkanes were also investigated. Finally, β-thiomannosides were synthesized from thiocycloalkane acceptors. - 37Mukhopadhyay, B.; Kartha, K. P. R.; Russell, D. A.; Field, R. A. J. Org. Chem. 2004, 69, 7758– 7760[ ACS Full Text
], [ CAS], Google Scholar37https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvVahtbY%253D&md5=80222926c97254fbbe5f23572f1b472aStreamlined Synthesis of Per-O-acetylated Sugars, Glycosyl Iodides, or Thioglycosides from Unprotected Reducing SugarsMukhopadhyay, Balaram; Kartha, K. P. Ravindranathan; Russell, David A.; Field, Robert A.Journal of Organic Chemistry (2004), 69 (22), 7758-7760CODEN: JOCEAH; ISSN:0022-3263. (American Chemical Society)Solvent-free per-O-acetylation of sugars with stoichiometric acetic anhydride and catalytic iodine proceeds in high yield (90-99%) to give exclusively pyranose products as anomeric mixts. Without workup, subsequent anomeric substitution employing iodine in the presence of hexamethyldisilane (i.e., TMS-I generated in situ) gives the corresponding glycosyl iodides in 75-95% isolated yield. Alternatively, and without workup, further treatment with di-Me disulfide or thiol (ethanethiol or thiocresol) gives anomerically pure thioglycosides in more than 75% overall yield. - 38Chervin, S. M.; Abada, P.; Koreeda, M. Org. Lett. 2000, 2, 369– 372[ ACS Full Text
], [ CAS], Google Scholar38https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtlWntg%253D%253D&md5=a3c7a9822b71b197d826f45795a7e2deConvenient, in Situ Generation of Anhydrous Hydrogen Iodide for the Preparation of α-Glycosyl Iodides and Vicinal Iodohydrins and for the Catalysis of Ferrier GlycosylationChervin, Stephanie M.; Abada, Paolo; Koreeda, MasatoOrganic Letters (2000), 2 (3), 369-372CODEN: ORLEF7; ISSN:1523-7060. (American Chemical Society)Anhyd. hydrogen iodide is generated in situ by the reaction of solid iodine and a thiol. The HI thus generated has been employed for the efficient prepn. of α-glycosyl iodides and vicinal iodohydrins from the corresponding glycosyl acetates and epoxides, resp., and for Ferrier glycosylation of alcs. and thiols. - 39Kováč, P.; Yeh, H. J. C.; Glaudemans, C. P. J. Carbohydr. Res. 1987, 169, 23– 34[ Crossref], [ PubMed], [ CAS], Google Scholar39https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXktlyjurc%253D&md5=2333129324e97a2dec8430b855593614Synthesis and NMR spectra of methyl 2-deoxy-2-fluoro- and 3-deoxy-3-fluoro-α- and β-D-glucopyranosidesKovac, Pavol; Yeh, Herman J. C.; Glaudemans, P. J.Carbohydrate Research (1987), 169 (), 23-34CODEN: CRBRAT; ISSN:0008-6215.Me 3-deoxy-3-fluoro-α- and β-D-glucopyranosides and α- and β-D-glucofuranosides were prepd. by methanolysis of 3-deoxy-3-fluoro-1,2:5,6-di-O-isopropylidene-α-D-glucofuranose. Cryst. 3,4,6-tri-O-acetyl-2-deoxy-2-fluoro-α-D-glucopyranosyl chloride (I) and bromide were prepd. from 1,3,4,6-tetra-O-acetyl-2-deoxy-2-fluoro-β-D-glucopyranose (II). Reaction of I with MeOH under the conditions of both silver triflate- and silver perchlorate-catalyzed glycosylation showed remarkable lack of stereoselectivity for the α-glycoside, despite the presence at C-2 of the F presumably not capable of neighboring-group participation. Pure Me 2-deoxy-2-fluoro-α- and β-D-glucopyranosides were obtained by fractional crystn. from the mixt. formed by methanolysis of II. The structure of these substances as well as of several other derivs. of 2-deoxy-2-fluoro- and 3-deoxy-3-fluoro-D-glucose were verified by (1H, 13C, and 19F) NMR.
- 40Michalik, M.; Hein, M.; Frank, M. Carbohydr. Res. 2000, 327, 185– 218[ Crossref], [ PubMed], [ CAS], Google Scholar40https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsVGrurw%253D&md5=c76bc46ef2e5671931d224f77405c480NMR spectra of fluorinated carbohydratesMichalik, Manfred; Hein, Martin; Frank, MichaelCarbohydrate Research (2000), 327 (1-2), 185-218CODEN: CRBRAT; ISSN:0008-6215. (Elsevier Science Ltd.)A review with 206 refs. on recent advances in structural and conformational anal. of fluorinated carbohydrates by NMR spectroscopy. Characteristic 1H, 13C, and 19F NMR chem. shifts and coupling consts. for selected examples are given and the spectral data of a series of fluorinated carbohydrates were collected in continuation of the review of Csuk and Glanzer.
- 41Abronina, P. I.; Kachala, V. V.; Kononov, L. O. Carbohydr. Res. 2009, 344, 240– 244[ Crossref], [ PubMed], [ CAS], Google Scholar41https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFOk&md5=418cb81cc1a412e0490f23e274c6819aA novel synthesis of β-D-mannopyranosyl azide by phase transfer catalysisAbronina, Polina I.; Kachala, Vadim V.; Kononov, Leonid O.Carbohydrate Research (2009), 344 (2), 240-244CODEN: CRBRAT; ISSN:0008-6215. (Elsevier Ltd.)A simple stereoselective synthesis of per-O-benzoyl-β-D-mannopyranosyl azide from per-O-benzoyl-α-D-mannopyranosyl bromide using phase transfer catalysis was developed. The stereochem. at C-1 of the anomeric O-benzoylated α- and β-D-mannopyranosyl azides was unambiguously established using 2D NOESY NMR spectroscopy. Pure deprotected β-D-mannopyranosyl azide was prepd. by debenzoylation with sodium methoxide in methanol.
- 42Hale, K. J.; Hough, L.; Manaviazar, S.; Calabrese, A. Org. Lett. 2014, 16, 4838– 4841[ ACS Full Text
], [ CAS], Google Scholar42https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFCjt7nF&md5=9b508c2db4ef5695f3d0cd03fb8347bfAn Update of the Rules for Pyranoside Sulfonate DisplacementHale, Karl J.; Hough, Leslie; Manaviazar, Soraya; Calabrese, AndrewOrganic Letters (2014), 16 (18), 4838-4841CODEN: ORLEF7; ISSN:1523-7052. (American Chemical Society)The original 1967 Richardson-Hough rules for predicting SN2 displacement viability in carbohydrate sulfonate derivs. with external nucleophiles have now been updated. Not only do the original rules still hold, but the newly updated rules rationalize why O-triflates (trifluoromethanesulfonate esters) frequently allow many seemingly "disallowed" pyranosidic nucleophilic substitutions to proceed. The new guidelines, which are based on three decades of exptl. evidence, allow the feasibility of many pyranosidic O-triflate SN2 displacements to be gauged beforehand. - 43Gamblin, D. P.; Garnier, P.; Ward, S. J.; Oldham, N. J.; Fairbanks, A. J.; Davis, B. G. Org. Biomol. Chem. 2003, 1, 3642– 3644[ Crossref], [ PubMed], [ CAS], Google Scholar43https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotleiurY%253D&md5=510159c1a828a2747a4b6599408e8ff5Glycosyl phenylthiosulfonates (Glyco-PTS): novel reagents for glycoprotein synthesisGamblin, David P.; Garnier, Philippe; Ward, Sarah J.; Oldham, Neil J.; Fairbanks, Antony J.; Davis, Benjamin G.Organic & Biomolecular Chemistry (2003), 1 (21), 3642-3644CODEN: OBCRAK; ISSN:1477-0520. (Royal Society of Chemistry)Controlled site-selective glycosylation can be achieved by combining site-directed cysteine mutagenesis with chem. modification of the introduced thiol. A new class of more efficient chemoselective reagents, glycosyl phenylthiosulfonates, allow rapid glycosylations of representative simple thiols, peptides and proteins.
- 44Černý, I.; Novotný, P.; Drašar, P.; Havel, M.; Pacák, J. Collect. Czech. Chem. Commun. 1989, 54, 2775– 2783[ Crossref], [ CAS], Google Scholar44https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXksVWisbo%253D&md5=55f60855494d1d46282de9617741fb28Steroids. Part CCCXLVI. Glycosylation of steroids with silver silicate and 2-deoxy-2-fluoro-α-D-glucopyranosyl bromide triacetateCerny, Ivan; Novotny, Petr; Drasar, Pavel; Havel, Miroslav; Pacak, JosefCollection of Czechoslovak Chemical Communications (1989), 54 (10), 2775-83CODEN: CCCCAK; ISSN:0010-0765.Glycosylation with the title glycosyl bromide in 1,2-dichloroethane in the presence of silver silicate and mol. sieves afforded mixts. of 3,4,6-tri-O-acetyl-2-deoxy-2-fluoro-α- and β-D-glucopyranosides, derived from Et (20E)-3β-hydroxy-24-nor-5,20(22)-choladien-23-oate, (20E)-3β-hydroxy-5β-pregn-20-ene-21-carboxylate and digitoxigenin, in which the β-anomers predominated. Sepn. and deacetylation furnished the resp. 2-deoxy-2-fluoroglucosides.
- 45Rempel, B. P.; Withers, S. G. Org. Biomol. Chem. 2014, 12, 2592– 2595[ Crossref], [ PubMed], [ CAS], Google Scholar45https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFWrtrc%253D&md5=2d1d9c9bf85d3ff61c8410440153700aPhosphodiesters serve as potentially tunable aglycones for fluoro sugar inactivators of retaining β-glycosidasesRempel, B. P.; Withers, S. G.Organic & Biomolecular Chemistry (2014), 12 (16), 2592-2595CODEN: OBCRAK; ISSN:1477-0520. (Royal Society of Chemistry)2-Deoxy-2-fluoroglycosides bearing dibenzyl phosphate and phosphonate aglycons were synthesized and tested as covalent inactivators of several retaining α- and β-glycosidases. β-D-Gluco-, -manno- and -galacto-configured benzyl-benzylphosphonate derivs. efficiently inactivated β-gluco-, β-manno- and β-galactosidases, while α-gluco- and α-manno-configured phosphate and phosphonate derivs. served instead as slow substrates.
- 46Rempel, B. P.; Tropak, M. B.; Mahuran, D. J.; Withers, S. G. Angew. Chem., Int. Ed. 2011, 50, 10381– 10383[ Crossref], [ PubMed], [ CAS], Google Scholar46https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFKhs7nM&md5=d08ad271c63e2f6e2f7cd8fbbfbf6878Tailoring the Specificity and Reactivity of a Mechanism-Based Inactivator of Glucocerebrosidase for Potential Therapeutic ApplicationsRempel, Brian P.; Tropak, Michael B.; Mahuran, Don J.; Withers, Stephen G.Angewandte Chemie, International Edition (2011), 50 (44), 10381-10383, S10381/1-S10381/25CODEN: ACIEF5; ISSN:1433-7851. (Wiley-VCH Verlag GmbH & Co. KGaA)The development of a new class of fluorosugar glycosidase inactivators bearing tunable phosphorus-based leaving groups that react with lysosomal β-Glucocerebrosidase over 4000 times faster than 2-deoxy-2-fluoro-β-D-glucosyl fluoride, is reported.
- 47Logue, S. E.; Elgendy, M.; Martin, S. J. Nat. Protoc. 2009, 4, 1383– 1395[ Crossref], [ PubMed], [ CAS], Google Scholar47https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVygsbvL&md5=563471996f250299c82e6bacc0f7d741Expression, purification and use of recombinant annexin V for the detection of apoptotic cellsLogue, Susan E.; Elgendy, Mohamed; Martin, Seamus J.Nature Protocols (2009), 4 (9), 1383-1395CODEN: NPARDW; ISSN:1750-2799. (Nature Publishing Group)Apoptosis is a mode of programmed cell death that is widely used to eliminate cells during development, tissue homeostasis, infection or in response to injury. Alterations to the plasma membranes of apoptotic cells trigger recognition and engulfment of such cells by phagocytes. Measurement of plasma membrane phosphatidylserine externalization, using fluorescently labeled annexin V, is widely used for the detection of apoptotic cells. Here the authors describe protocols for bacterial expression, purifn. and FITC labeling of recombinant annexin V. By following the method outlined in this protocol, it is possible to produce milligram amts. of recombinant annexin V within 3 d. The authors also describe a method for the assessment of annexin V binding to cell populations by flow cytometry or fluorescence microscopy.
Supporting Information
ARTICLE SECTIONSExperimental details, VT-NMR experiments, characterization data, and copies of 1H, 13C, and 19F NMR spectra for all new compounds. The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acs.orglett.5b01259.
Terms & Conditions
Electronic Supporting Information files are available without a subscription to ACS Web Editions. The American Chemical Society holds a copyright ownership interest in any copyrightable Supporting Information. Files available from the ACS website may be downloaded for personal use only. Users are not otherwise permitted to reproduce, republish, redistribute, or sell any Supporting Information from the ACS website, either in whole or in part, in either machine-readable form or any other form without permission from the American Chemical Society. For permission to reproduce, republish and redistribute this material, requesters must process their own requests via the RightsLink permission system. Information about how to use the RightsLink permission system can be found at http://pubs.acs.org/page/copyright/permissions.html.




